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CHAPTER 1
INTRODUCTION
Ionizing Radiation
Ionizing radiation (IR) is a type of energy or particle that can remove tightly
bound electrons from the orbit of atoms and cause them to become charged or ionized.
IR can lead to chromosome damage causing cancer, yet IR is also used for treating
tumors because of its ability to kill cells by inducing DNA double strand breaks. Four of
the most commonly evaluated types of IR are alpha particles, beta particles, photons
(gamma and x-rays), and fast neutrons. Figure 1.1 indicates the penetrating powers of
these four radiation types.

Figure 1.1 Penetrating powers of different radiation types. The yellow circles represent
protons or electrons indicated with a "+" or "-" sign, respectively. The green circles are
the neutrons that are uncharged particles. The red zig-zag line denotes the
wave/particle nature of gamma and x-rays.
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These four radiation types differ in the kind, energy and/or charge of the particle
emitted and in their penetrating powers. Alpha particles are identical to a helium nucleus
and usually consist of two protons and two neutrons. Beta particles are negatively
charged electrons. Gamma rays and X-rays are photons which are discrete bundles of
energy that exhibit both wave- and particle-like properties. Neutrons are highly
energetic, uncharged particles that are highly penetrating and can cause severe DNA
damage.
Exposure to IR can occur naturally, e.g. from radon decay that produces alpha
particles, and cosmic rays which are high-energy radiations originating from outside the
solar system. Man made sources of IR exposure occur from diagnostic procedures such
as CT scans, PET scans, X-rays, radiotherapy, radiation incidents and occupational
exposures. Radiation can either interact with cells directly causing damage to the DNA
double helix or indirectly by interacting with water molecules that surround the DNA and
producing free radicals leading to oxidative damage and hence damaging the DNA.
Chapters 2, 3 and 4 of this Dissertation present important findings on biological
effects of radiation in human cells. This research provides a fundamental contribution to
the field of radiation biology because it adds to our current knowledge about neutron
radiation and effects of low-doses of gamma rays in human cells.

Neutrons
Neutrons are highly energetic uncharged particles that can be generated from
accelerators and cyclotrons, and from decay of radioisotopes such as Californium-252.
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Neutrons are the main component of cosmic radiation and are highly penetrating. The
relative biological effectiveness of neutrons is between 2 to 6 compared to photons [1],
meaning that 2 to 6 times less neutron dose than photon dose is needed to produce the
same amount of DNA damage. The differential radiosensitivity between poorly
oxygenated (more resistant) and well-oxygenated (more sensitive) cells, is reduced with
neutrons. Hence, neutrons are more effective in controlling certain tumor types where
conventional photon therapy is ineffective [2]. Unlike low linear energy transfer (LET)
radiation (e.g. photons), for neutrons which are high-LET radiation, there is also a
reduction in the differential radiosensitivity of cells related to their position in the cell
cycle [3]. Patients receiving neutron or proton therapy are exposed to neutrons during
treatment. In addition, astronauts, airline crews and aircraft passengers are exposed to
cosmic radiation which includes neutrons. Other possible sources of neutron exposure
to humans may include occupational exposure or radiation incidents such as the
Hiroshima-Nagasaki atomic bomb explosions that occurred nearly 70 years ago, and
the much more recent tsunami-induced radiation accident at the Fukushima Daiichi site
in Japan. The radiation released from the reactors was reported to contain neutrons in
addition to other radioactive particles [4].
Direct effects of neutron exposure are well known, however, not much is known
about non-targeted effects (i.e. the consequences to cells neighboring the directly
irradiated cells) of neutrons. Chapter 3 describes a study I performed to determine
whether or not neutrons induce a bystander effect in human cells.
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Bystander effect
One of the major paradigm shifts in the field of radiation biology was the
discovery of the bystander effect in which cells in the vicinity of irradiated cells behave
as though they were irradiated [5]. Thus, directly exposed cells are not the sole targets
of radiation. The bystander effect has been observed repeatedly in mammalian cell lines
in response to IR particularly consisting of photons [6-8]. Depending on the cell type, the
bystander effect can be transmitted either through culture medium [9] or through cell-tocell contact [10]. A detailed list of candidate signaling molecules that may be involved in
the bystander effect is included in Chapter 3. Many studies have been performed on the
radiation-induced bystander effect using photons on various cell lines, including human
skin fibroblasts [11], epithelial cells [9] and leukemic cells [12, 13]. However, there is no
conclusive evidence concerning a neutron-induced bystander effect in human cells.
The occurrence of the bystander effect has significant implications for risk
estimation of therapeutic treatments involving radiation. Such non-targeted effects
induced by radiation may have serious implications for human health and might cause
cancer. Therefore, the risks of radiation exposure need to be analyzed in terms of both
direct and indirect exposures.
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Cytokinesis Block Micronucleus Assay (CBMN)
The CBMN assay is a well-established cytogenetic method for measuring DNA
damage after exposure to radiation and other clastogens. In this assay, cells are treated
with cytochalasin B to block cytokinesis leading to the formation of binucleated cells,
which are first division mitotic cells that contain all the products of one mitosis inside the
cell membrane. Micronuclei (MN), nuclear buds and nucleoplasmic bridges are the
three different genetic endpoints that can be visualized and measured simultaneously in
this assay. The major advantages of the CBMN assay are that it is reliable, simple to
perform, fast, and sensitive. A single binucleated cell can have one or more of any of
these three nuclear anomalies present individually or together. The molecular
mechanisms behind two of the three CBMN outcomes, i.e. MN and nucleoplasmic
bridges, are well known [14]. However, the mechanism of formation of nuclear buds is
still unclear. MN are formed from acentric chromosomes or chromatid fragments, or
when there is malsegregation of chromosomes during anaphase leading to a lagging
chromosome. A single micronucleus can consist of one or more whole chromosomes
and/or acentric fragments [15]. Nucleoplasmic bridges are formed when the two
centromeres of a dicentric are pulled towards opposite poles during anaphase. Although
the exact mechanism remains unclear, nuclear buds are thought to be formed in the
process of elimination of nuclear material from the nucleus [14]. Complete details of the
procedure of the CBMN assay are provided in Chapters 2 and 3. Cells can be stained
either with Giemsa (Figure 1.2) or acridine orange (Figure 1.3).
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a)

b)

c)

Figure 1.2 Images of binucleated cells with and without MN stained with Giemsa: a)
normal binucleated cell; b) a binucleated cell with one MN; c) a binucleated cell with one
MN, one nucleoplasmic bridge and a nuclear bud.
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a)

b)

c)

Figure 1.3 Images of binucleated cells with and without MN stained with acridine
orange: a) a binucleated cell with a bud; b) a binucleated cell with two MN and one
nucleoplasmic bridge; c) a binucleated cell with two MN and three bridges.
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Low-dose hyper-radiosensitivity (HRS)
Some of the major effects of high doses of radiation have been known for over a
century [16]. However, studies of the effects of low doses of IR have been limited by
the lack of significant observable effects to the human body. One of the most important
issues concerning radiation risk assessment is validation of linear-no-threshold (LNT)
models. According to LNT models, the risks of genetic damage increase linearly with
dose without any threshold. Due to the lack of conclusive evidence of radiation risks at
very low doses, radiation protection committees assume that LNT models are true and
that responses are linear at low doses [17-19]. However, phenomena such as low-dose
hyper-radiosensitivity (HRS), that argue against conventional linear-no-threshold
models, have been demonstrated both in vivo and in vitro in response to photons [17].
Figure 1.4 represents the different possible outcomes of the radiation dose response
relationship in the very low dose region.
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Figure 1.4 Expected outcomes of the radiation dose response relationship in
the very low dose region. The diagonal line in the top graph coupled with the
dotted blue line in the bottom graph represent a linear-no-threshold model
that is currently followed by regulatory agencies to predict low-dose radiation
risks, e.g. for cancer. The bottom graph shows two other possible outcomes
of the shape of the low-dose radiation response curve for cytogenetics,
where the red line depicts low-dose radiation hypersensitivity. The green line
represents a threshold model where there is no damage below a certain
dose.

Regulatory agencies use LNT models to extrapolate risks to low doses from high
doses. The existence of HRS effects contradict LNT models and provides evidence of
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non-linearity in the low dose region. In HRS, irradiated cells are at higher risk of
damage per unit dose than is the case at higher doses. HRS is more prominent in the
G2 phase compared to cells in the G1 or S phases of the cell cycle [19]. The existence
of HRS in clonogenic survival experiments suggests that G2 phase cells with DNA
damage enter mitosis due to failure of ATM-dependent DNA repair processes [18]. The
damage induced by low doses of radiation is not enough to activate the DNA repair
machinery. In other words, the slope of the response curve at very low doses may be
significantly steeper than at higher doses. HRS may have implications in risk analysis
because deviation from LNT models could necessitate a re-evaluation of radiation
protection standards. The biological effects of low dose radiation and the risks
associated with these effects must be considered while carrying out diagnostic and
therapeutic treatments involving radiation. Chapter 4 presents the first cytogenetic
evidence of low-dose hypersensitivity in human cells in response to gamma rays using
structural chromosomal aberrations as the end-point.

Structural Chromosome Aberrations
One of the most sensitive yet labor intensive cytogenetic endpoints is structural
chromosome aberrations. There is solid mechanistic evidence of an association of
chromosomal aberrations and cancer risk, e.g. [20]. Most cancers have been
associated with some form of chromosomal rearrangement (reviewed in [21]). Structural
chromosomal aberration frequencies are considered to be one of the most relevant and
effective biomarkers of radiation exposure [20, 22].
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There are two major types of structural chromosomal aberrations: chromosometype and chromatid-type. According to the classical theory of formation of chromosomal
aberrations [23], if DNA damage occurs when the cell is in the G1 phase then that will
lead to chromosome-type aberrations versus chromatid-type aberrations that are
formed if DNA damage occurs in G2. Figure 1.5 demonstrates the mechanism of
formation of some structural chromosomal aberration types. Translocations are well
known biomarkers of exposure to radiation and are often the preferred aberration type
to perform radiation dosimetry [24]. Compared to other chromosome aberrations such
as dicentrics, translocations persist for significantly longer times after radiation exposure
[25].
There are different methods for visualizing structural chromosomal aberrations.
These include Giemsa staining of unbanded chromosomes [26] and fluorescent in situ
hybridization (FISH) painting [27]. Giemsa stain is inexpensive but scoring Giemsa
stained chromosomes can be challenging and labor intensive. FISH painting probes are
very expensive but scoring these cells is comparatively easy and less labor-intensive
than scoring Giemsa-stained chromosomes. FISH-painting is not needed for identifying
chromatid exchanges, and may in fact interfere with their identification because painting
involves denaturation of the chromosomes, which can obscure some of the more subtle
changes in certain chromosomal aberrations. With Giemsa staining all kinds of
chromatid-type damage (e.g. triradials and quadriradials) and much of the chromosometype damage including dicentrics, fragments, and rings can be clearly identified. The
major disadvantage of Giemsa staining is that many translocations, insertions,
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deletions, and duplications cannot be identified [28]. Figure 1.6 shows pictures of
Giemsa stained chromosomes in metaphase.
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a)
G2 phase,
metaphase
Reciprocal
translocation

G1 phase

DNA replication

Repair

Dicentric plus
fragment

b)

Figure 1.5 Mechanism of formation of some structural chromosomal aberrations. a) a
break in each of two non-homologous chromosomes (depicted by yellow and red
colors) in G1 can either lead to a stable rearrangement called a reciprocal translocation
where there is an exchange of fragments or it can lead to the formation of a dicentric
and an acentric fragment; b) a break in one of the chromatids in each of two
chromosomes in G2 can lead to an exchange of chromatid fragments resulting in
formation of a quadriradial.
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a)

b)

c)

Figure 1.6 Examples of cells in metaphase stained with Giemsa showing structural
chromosomal aberrations: a) normal human cell in metaphase stained with Giemsa; b)
cell with an asymmetrical chromatid exchange (“quadriradial”) and chromatid breaks
(arrows); and c) cell with a dicentric and a fragment next to it (arrow).
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Future Directions
Neutrons and the bystander effect
Chapter 3 answers an important question regarding whether neutrons induce a
bystander effect in human cells. Even though neutron therapy has the potential to treat
tumors that cannot be treated as effectively by photon radiotherapy or chemotherapy,
no conclusive evidence exists to support or refute the existence of non-targeted effects
of neutrons in human cells. Information obtained from this study will facilitate refined
estimates of the risk-benefit ratio of neutron therapy and may be valuable to those who
are concerned about the health effects of exposure during space travel. Understanding
the biological effects of neutrons may also enable more refined evaluations of the
standards for radiation protection and safety.
Characterization of the radiation response curve at low doses
Chapter 4 provides cytogenetic evidence of low-dose hyper-radiosensitivity in the
G2 phase in human peripheral blood lymphocytes. This is the first time that the shape of
the radiation dose response curve in G2 has been characterized at such low doses
using structural chromosomal aberrations. Determining the shape of the low-dose
response may lead to improvements in the evaluation of radiation risks. Low-dose
radiation hypersensitivity could be exploited clinically if radiotherapy were delivered in a
large number of dose fractions, each of which is less than 0.5 Gy. The net effect of lowdose hypersensitivity on cancer risks in cell populations and tissues will depend on
whether the increased damage occurring at these low doses results in increased
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cytotoxicity and/or more survivable mutations. Further work needs to be done to couple
mutational assays with the ultimate fate of cells after damage by low doses of radiation.
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CHAPTER 2
This chapter has been previously published in the journal “Mutagenesis”. I am a
joint first-author on this paper. In this chapter I have only included data from this paper
that are from experiments I performed myself. The citation of this paper is:
Cheong HS, Seth I, Joiner MC, Tucker JD., 2013. Relationships among micronuclei,
nucleoplasmic bridges and nuclear buds within individual cells in the cytokinesis-block
micronucleus assay. Mutagenesis 28:433-440.

Relationships among micronuclei, nucleoplasmic bridges and nuclear buds
within individual cells in the cytokinesis-block micronucleus assay

INTRODUCTION
Cytogenetic analyses have been used to answer many questions concerning the
effects of ionizing radiation and potentially clastogenic chemicals in a wide variety of
organisms. The cytokinesis-block micronucleus (CBMN) assay is a well-established
method that can be used to measure DNA damage in human lymphocytes [1]. This
assay involves the application of cytochalasin B, an inhibitor of actin polymerization, to
block cytokinesis in mitotic cells. Cells undergoing a single round of mitosis thus
become binucleated and are easily distinguished from undivided cells. The CBMN
assay is a multi-endpoint method that can be used to measure different biomarkers of
DNA damage. The three different end points that can be analyzed simultaneously in this
assay are micronuclei, nucleoplasmic bridges and nuclear buds.
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Until recently, most studies involving the CBMN assay have considered only
micronucleus frequencies and have not evaluated bridges or buds. Micronucleus
frequencies are not always simple to interpret because micronuclei may originate by
many mechanisms. The action of clastogens gives rise to micronuclei that contain
mainly acentric chromosome or chromatid fragments, and these can occur through DNA
double-strand breaks (DSBs), or single-strand breaks that are converted into DSBs after
DNA replication, or inhibition of DNA synthesis [2]. Micronuclei may also result from
lagging whole chromosomes in mitosis due to spindle attachment errors, defects in
centromeres and/or kinetochores or abnormal cell cycle check points [2]. Furthermore,
micronuclei may be generated by elimination of double minutes by nuclear budding or
lagging of double minutes in mitosis [3]. The fragmentation of nucleoplasmic bridges
has also been observed to result in the formation of micronuclei [4]. Several
modifications that have been made to the assay enable determination of the origins of
the induced micronuclei; e.g. the effects of aneugenic or clastogenic agents can be
identified using centromere-specific DNA probes or anti-kinetochore antibodies [5-7].
Nucleoplasmic bridges are another indicator of DNA damage and are easily
observable alongside micronuclei in the CBMN assay, requiring no additional sample
preparation. Bridges originate from dicentric chromosomes which are formed through
misrepair of DNA breaks and telomere fusion events [8, 9]. Due to these highly specific
origins, scoring of bridges may aid in the interpretation of micronucleus data or provide
additional information that is not available through the scoring of micronuclei alone.
Previous work has also shown that both micronuclei and bridge induction occur in
response to ionizing radiation and reactive oxygen species, and that these increases
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are highly correlated [10]. In addition, high correlations between these three genetic end
points have been shown in response to folic acid deficiency [11, 12].
Nuclear buds may also be observed with the CBMN assay. Buds have been
shown to form by the elimination of amplified extrachromosomal DNA during interphase
as an intermediate step in the formation of double minute-type micronuclei [3, 13], and
also occur from the remnants of broken nucleoplasmic bridges [14]. A correlated
increase in micronuclei and buds has been demonstrated in cells treated with mitomycin
C or Colcemid® [15].
Many improvements in the CBMN assay have been made since it was first
described [16]. Although studies evaluating the effects of many DNA damaging agents
including ionizing radiation and chemicals such as mitomycin C [17] and phleomycin
[18] have been performed using this assay, there are no published data describing the
statistical associations among micronuclei, bridges and buds within each cell. These
three end points are important because of the different mechanisms by which each
arises. This might yield insights into the different kinds of damage to cells. In the current
study, cells treated with gamma radiation and neutron radiation were analyzed. Here we
report that the presence of any one of these three genetic end points in a given cell is
significantly associated with an increased probability for the presence of the remaining
two outcomes.
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MATERIALS AND METHODS
Cell lines
Two normal human lymphoblastoid cell lines, GM15510 and GM15036, were
obtained from the Coriell Cell Repository.

Cell culture techniques
Cells were cultured according to the standard protocol provided by Coriell. Cells
were grown in T25 or T75 CellStar vented suspension culture flasks (Greiner Bio-one)
containing RPMI-1640 medium (Thermo Scientific) that was supplemented with 15%
fetal bovine serum (Atlanta Biological). In addition, penicillin-streptomycin (100 U/mL
penicillin, 100 µg/mL streptomycin) (Gibco), 2 mM L-glutamine (Gibco), and 2.5 µg/mL
amphotericin B (Thermo Scientific) were added to the medium. The volumes of culture
did not exceed 20 mL for T25 flasks or 60 mL for T75 flasks. Cell culture flasks were
kept in a fully humidified incubator at a temperature of 37°C and CO 2 concentration of
5%. Cells were seeded at 3 × 105 cells/mL and passaged when the concentration
reached approximately 1 × 106 cells/mL (3-6 days from time of previous passage
depending on the cell line). Cells were fed at intervals of 3 days after passage by careful
removal of approximately half of the culture medium in flasks without disturbing
sedimented cells, and addition of the same volume of fresh cell culture medium. All cell
culture media were pre-warmed to 37°C before use.
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Experimental design for gamma radiation and neutron radiation
Cells were seeded at 3.0 × 105 cells/mL in 10 mL of culture medium in T25 nonvented flasks (Greiner Bio-one) and incubated overnight with loosened caps. All
irradiations were performed in the Gershenson Radiation Oncology Center, Wayne
State University, Detroit, Michigan. For neutron exposures the cells were cultured in T25
flasks but immediately prior to irradiation the cells were transferred to polypropylene
Falcon tubes (Evergreen Scientific, Los Angeles, CA). A cyclotron was used to generate
d(48.5)-Be neutrons with the dose rate of 0.3 Gy/min at doses of 0 (control), 0.5, 1, 1.5,
2, 3 and 4 Gy. Following exposure the cells were returned immediately to the laboratory,
transferred to new T25 culture flasks, and incubated as described. For the neutron
radiations given with this clinical machine, six percent of the total dose (neutrons plus
gamma rays) is due to contamination from γ-radiation produced mostly by the
absorption of neutrons in the beam collimator, as is always the case with particle
irradiators. For evaluation of damage induced by low-dose γ-radiation only, cultures of
GM15510 and GM15036 were acutely irradiated with a Cobalt-60 source using a
Theratron radiotherapy unit (Atomic Energy of Canada), with the dose rate of 0.25
Gy/min. The doses used were equivalent to the six percent contamination of γ-radiation
in the neutron beam exposures, i.e. 0 (control), 0.03, 0.06, 0.09, 0.12, 0.18 and 0.24 Gy.
To evaluate effects of higher doses of γ-radiation, cells were also irradiated in a
separate experiment with γ-radiation doses of 0 (control), 0.5, 1, 2, 3 and 4 Gy. For γradiation, cells were cultured in T25 flasks and irradiated, after which they were brought
back to the laboratory and returned to the incubator for four hours.
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Cytokinesis-block micronucleus assay
Following four hours of incubation, 6 µg/ml of cytochalasin B (Sigma) was added
to each culture. A stock of 600 µg/mL cytochalasin B in dimethyl sulfoxide was used, for
a final dimethyl sulfoxide concentration of 1% in treated cultures. Twenty eight hours
after addition of cytochalasin B, cells were harvested by centrifugation onto ethanolcleaned glass slides using a StatSpin Cytofuge 2 cytocentrifuge. After drying briefly in
air, the cells were fixed in 100% methanol for 15 minutes.

Giemsa staining and slide preparation
Fixed slides were immersed in 5% Giemsa, prepared by diluting 2.5 mL Giemsa
stain (Acros Organics) in 47.5 mL dH2O, for 20 minutes. Slides were then rinsed briefly
in dH2O and air-dried. For long-term storage, slides were mounted with a drop of
Permount (Fisher Scientific) and 22x22 mm2 or 25x25 mm2 glass coverslips.

Data collection
All slides were read by trained scorers on Nikon Eclipse E200 light microscopes
at 1000× magnification, and were coded prior to scoring to prevent observer bias. For
0.5 Gy to 4 Gy γ-irradiated slides, approximately 500 cells were scored by each of two
trained people for a total of approximately 1000 binucleated cells per treatment group.
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For cell lines treated with neutron radiation or low-dose γ-radiation (0.03 Gy to
0.24 Gy), 1,200 to 18,000 binucleated cells were scored for each treatment condition. A
large number of cells had to be scored for low doses of γ-radiation because these doses
induce low levels of damage for each of the three biomarkers. The scoring was
performed by trained observers and was balanced between 2 to 4 scorers such that for
each dose, each scorer evaluated approximately the same number of cells.
To determine whether there were enough binucleated cells for each treatment
condition, the mean number of nuclei per cell was determined by counting 300 to 400
cells. These data indicated that the numbers of binucleated cells were high enough to
enumerate micronuclei, bridges, and buds for every treatment condition except for cells
irradiated with 3 or 4 Gy neutrons. For low doses of photons, determination of the mean
number of nuclei was not necessary because doses higher than these had enough
binucleated cells to enumerate all three end points.

Cell scoring criteria
Cells were scored essentially according to established criteria [19, 20], with
refinements as illustrated in Figure 2.1. For the neutron experiments, all binucleated
cells with non-overlapping nuclei were included for evaluation; this includes cells where
the two nuclei were touching each other, as shown in Figure 2.1b and 2.1c. This
approach is referred to here as the “relaxed” criteria. For the γ-radiation experiments,
the nuclei were required to be well-separated and not in contact with each other at any
point, as shown in Figure 2.1d. This approach is referred to here as the “stringent”
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criteria. For all experiments the cells were also required to have fully intact cytoplasm
with boundaries that were clearly distinct from adjacent cells. All cells were evaluated
simultaneously for three different end points: micronuclei, bridges, and buds, and the
coincident presence of these endpoints within individual cells were recorded. Entities
were considered to be micronuclei if they had similar color and texture to the main
nuclei, had a diameter of less than one-third that of the main nuclei, were round or oval
with a clear and well-defined boundary, and were located fully within the cytoplasm.
Nucleoplasmic bridges were considered to be fully continuous extensions of
nucleoplasm that spanned from one nucleus to the other, with similar staining
characteristics to nuclei. Nuclear buds were required to appear similar to micronuclei
and had to be visibly attached to a single main nucleus via a stalk that was narrower
than the widest point across the bud.
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Figure 2.1 Human binucleated lymphoblastoid cells showing (a) overlapping nuclei, (b,
c) touching nuclei, and (d) well-separated nuclei. The cells in (b), (c), and (d) were
counted when using the relaxed criteria for the CBMN assay, while only cells of the type
shown in (d) were counted using the stringent criteria which enabled observation of the
nucleoplasmic bridges.

Statistical analyses
The odds ratios for the presence of micronuclei, bridges and buds in cells were
calculated for each radiation dose for each cell line within each treatment condition.
Homogeneity of the odds ratios within the treatment sets were evaluated by Woolf’s test
of heterogeneity [21]. If no significant heterogeneity of the odds ratios was found, the
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hypotheses that the common odds ratios for each cell line within each treatment group
were greater than 1 was evaluated by the Mantel-Haenszel Chi-square test with
continuity correction [22]. All statistical analyses were performed using R version 2.15.0
with the vcd package version 1.2-13.
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RESULTS AND DISCUSSION
All treatment of cell lines with γ-radiation or neutron radiation induced a radiation
dose-dependent increase in micronuclei, bridges and buds (Figure 2.2).

Figure 2.2 Induction of micronuclei, nucleoplasmic bridges and nuclear buds evaluated
with the CBMN assay in two normal human lymphoblastoid cell lines irradiated with (a)
neutrons, (b) low doses of Cobalt-60 γ-radiation and (c) high doses of Cobalt-60 γradiation. Cells scored in (a) and (b) were evaluated using the relaxed criteria, while
cells in (c) were evaluated with the stringent criteria as described in the Materials and
Methods section.
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All cell lines showed decreases in the average number of nuclei per cell with
increasing radiation dose, consistent with increasing cytotoxicity of the treatments with
dose (Tables 2.1 and 2.2). The dose responses shown by these data are in general
agreement with prior work from our laboratory [18, 23].
Table 2.1. Average number of nuclei per cell for cultures treated with Cobalt-60
γ-radiation.
γ-radiation dose (Gy)
0
0.5
1
2
3
4

Nuclear division index
GM15510
GM15036
1.61
1.33
1.54
1.28
1.50
1.25
1.14
1.18
1.08
1.10
1.05
1.15

Table 2.2. Average number of nuclei per cell for cultures treated with neutrons.
Neutron radiation dose
(Gy)

Nuclear division index

GM15510
GM15036
0
1.73
2.01
0.5
1.50
1.65
1
1.37
1.42
1.5
1.11
1.21
2
1.21
1.12
3
1.08*
1.05*
4
1.09*
1.06*
*indicates too few binucleated cells to score for micronuclei, bridges, and buds.
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Two different approaches to scoring binucleated cells were used in this study;
these differed with respect to the physical distance that was required to exist between
the two nuclei in each cell being considered for analysis. The “stringent” scoring criteria
required the nuclei to have substantial distance between them, while the “relaxed”
scoring criteria allowed the nuclei to be touching, as shown in Figure 2.1. Only the
scoring itself differed between each set of criteria; slides were otherwise prepared with
identical materials and procedures, and criteria for determining whether an entity within
the cytoplasm was to be considered a micronucleus, bridge or bud were unchanged. To
evaluate the effects of increasing the stringency of scoring criteria on counts of
micronuclei, bridges and buds, a single observer scored eleven slides of γ-irradiated (0,
0.5, 1, 2, 3 and 4 Gy) normal human lymphoblastoid cells. Each of these slides was
evaluated first with the relaxed criteria and subsequently with the stringent criteria. A
direct comparison of the results produced by these two scoring methods showed that
while micronuclei and bud frequencies did not differ substantially between the two
criteria, the frequency of bridges was two-fold higher when evaluated with the stringent
criteria compared to the relaxed criteria (data not shown). This higher value may better
represent the true frequency of bridges in these samples. However, it should be noted
that use of the stringent criteria also resulted in nearly a seventy percent reduction in
the number of scoreable cells obtained from each slide. This comparison of scoring
methods suggests that the use of stringent criteria aids significantly in the observation of
bridges compared to the relaxed criteria, with the caveat of an almost three-fold
reduction in the number of scoreable cells. Two strategies that may be used in the
future to help overcome this large loss of scoreable cells are to increase the number of
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cells per slide and to increase the proportion of scoreable cells. The first may be
achieved by using a higher concentration of cells when spinning them onto slides. The
second may be carried out by increasing the centrifugation speed and perhaps by
hypotonic pre-treatment of cells.
Cells treated with either γ-radiation or neutron radiation were then evaluated
using either the stringent or the relaxed criteria, with cell counts ranging from 1000 to
18,000 binucleated cells depending on the treatment condition, with lower doses
generally having more cells counted. Three different cytogenetic endpoints, i.e.
micronuclei, nucleoplasmic bridges, and buds, were evaluated simultaneously in each
cell, regardless of the scoring criterion employed, and the number of cells with at least
one of these endpoints present ranged from a low of 45 in control treatments to a high
of 1078 in irradiated cultures. For each treatment condition, all the common odds ratios
for the presence of micronuclei and nucleoplasmic bridges were found to be significantly
higher than 1.00 (Table 2.3), indicating that the presence of bridges is a significant risk
factor for the presence of micronuclei within a cell, and vice versa.
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Table 2.3. Common odds ratios for the associations between MN and bridges, MN
and buds, and buds and bridges.
Associated
events
MN and
Bridges

MN and Buds

Buds and
Bridges

Treatment

Common odds ratio estimates
GM15510

GM15036

Neutron radiation

7.71

4.79

γ-radiation (low doses)

15.38

5.33

γ-radiation (high doses)

6.69

4.96

Neutron radiation
γ-radiation (low doses)

2.69
5.39

2.64
6.88

γ-radiation (high doses)

―†

1.50

Neutron radiation

4.43

4.57

γ-radiation (low doses)

5.55

6.94

γ-radiation (high doses)

2.34

―†

† Common odds ratio could not estimated due to significant heterogeneity (p <
0.05) in the odds ratios

Additionally, within each cell line, the odds ratios for the presence of micronuclei
and bridges for each treatment condition do not differ significantly from each other
(Figure 2.3a, 2.4a and 2.5a), indicating that the effects of the presence of bridges on the
presence of micronuclei (and vice versa) are fairly constant despite changes in radiation
doses. In addition, between the two normal human lymphoblastoid cell lines, the
common odds ratios for micronuclei and bridges for both types of radiation are similar.
This suggests that regardless of the genotype, the mechanism for the formation of
micronuclei and bridges remains the same in different cell lines and for different types of
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radiation. These relationships were consistent across both the stringent and the relaxed
scoring criteria despite the differences in the frequencies of bridges as already shown.

Figure 2.3 Odds ratios for the simultaneous presence (a) of micronuclei (MN) and
nucleoplasmic bridges, (b) micronuclei and buds, and (c) bridges and buds in two
normal human lymphoblastoid cell lines treated with neutrons. Some upper confidence
intervals have been truncated to provide a closer look at the data. Missing values at the
0-doses indicate that the odds ratio could not be calculated due to a lack of cells
containing one or both of the two endpoints being evaluated.
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Figure 2.4 Odds ratios for the simultaneous presence (a) of micronuclei (MN) and
nucleoplasmic bridges, (b) micronuclei and buds, and (c) bridges and buds in two
normal human lymphoblastoid cell lines treated with low doses of γ-radiation from a
Cobalt-60 source. Numbers inside the truncated bars indicate the value of that
observation. Some upper confidence intervals have been truncated to provide a closer
look at the data. Missing values at some doses indicate that the odds ratio could not be
calculated due to a lack of cells containing one or both of the two endpoints being
evaluated.
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Figure 2.5 Odds ratios for the simultaneous presence (a) of micronuclei (MN) and
nucleoplasmic bridges, (b) micronuclei and buds, and (c) bridges and buds in two
normal human lymphoblastoid cell lines treated with high doses of γ-radiation from a
Cobalt-60 source. Numbers inside the truncated bars indicate the value of that
observation. Some upper confidence intervals have been truncated to provide a closer
look at the data. Missing values at some doses indicate that the odds ratio could not be
calculated due to a lack of cells containing one or both of the two endpoints being
evaluated.
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From a mechanistic standpoint, these observations may be explained by
asymmetrical chromosome exchanges that result from the misrepair of DNA doublestrand breaks, where each such event leads to rearrangements that generate an
acentric chromosome fragment and a dicentric chromosome. Many of these dicentrics
and fragments would emerge in the next metaphase as bridges and fragments,
respectively, and the fragments could also appear in the next interphase as micronuclei.
The breakage-fusion-bridge cycle, a mechanism of chromosome instability involving
repeated cycles of fusion between chromosomes or chromatids and their subsequent
breakage during cell division as centromeres separate [9, 24] has been proposed to
explain the observation that the presence of micronuclei, bridges and buds are highly
correlated in folic acid-deficient cells [11, 12]. The same is not likely in this experiment,
as cells are treated with cytochalasin B four hours following irradiation, thus preventing
cells from undergoing more than one cell division after the initial damage. Therefore,
mechanisms other than the breakage-fusion-bridge cycle must be significant
contributors in our observation of correlated increases in micronuclei, bridges and buds.
Our results suggest that not only do asymmetrical chromosome exchanges
account for a fixed, observable proportion of the micronuclei and bridges generated by
treatment with ionizing radiation, but also that the CBMN assay is capable of detecting
such events. The frequency of micronuclei may provide an estimate of the number of
acentric fragments produced in response to a treatment. Similarly, the frequency of
nucleoplasmic bridges may be a reliable indicator of the number of dicentrics present
[10]. By producing a calibration curve comparing the number of dicentric and acentric
chromosomes from Giemsa-stained metaphase spreads to the micronuclei and bridge
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frequencies induced in CBMN assay, it may be possible to predict the results of one
assay without performing the other. Cells undergoing apoptosis and necrosis were not
recorded in this study; these biomarkers may affect the relationships between
micronuclei, buds and bridges. More studies are required to investigate this further.
Positive associations, as evaluated by odds ratios, also occurred for the
presence of micronuclei and nuclear buds (Figure 2.3b, 2.4b, 2.5b), and for the
presence of nucleoplasmic bridges and nuclear buds (Figure 2.3c, 2.4c, 2.5c) within
each cell in cell lines treated with γ-radiation or neutron radiation. While it is known that
certain types of micronuclei arise by nuclear budding, and that some buds arise from
the breaking of bridges, it is unclear how these simple relationships would lead to an
increased concurrent presence of buds with bridges or micronuclei in each cell. An
alternative explanation is that certain cells within the cell population have increased
susceptibility to DNA damage; variability in radiosensitivity of individual cells based on
their phase in the cell cycle is known to occur [25]. Thus, the positive associations
between the different endpoints in individual cells may be due (at least in part) to an
increased frequency of radiation damage within this certain subset of cells [25].
Unlike the odds ratios between micronuclei and bridges, and between bridges
and buds, the odds ratios for the presence of micronuclei and buds were found to be
heterogeneous for 2 of the 6 treatment sets examined. This suggests that the
association between micronuclei and buds is not static among various treatment
conditions but may be dependent on radiation dose. However, it should also be
cautioned that the visual means used to identify buds in the CBMN assay may allow
mis-identification of a small number of micronuclei as buds, as micronuclei in contact
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with cell nuclei may not easily be determined to be separate through visual means
alone. Thus, the possibility remains that any statistical association involving buds could
be due to micronuclei that were incorrectly identified as buds.
In conclusion, in cells treated with γ-radiation and neutron radiation, the
occurrence of micronuclei, bridges and buds within individual cells are positively
associated with each other. This suggests the existence of a common mechanism of
generation for these endpoints by chromosomal damage and structural chromosome
rearrangements. Differences in radiosensitivity of individual cells within the cell
population according to their position in the cell cycle at the time of exposure may also
be important. Altering the scoring criteria of the CBMN assay such that only binucleated
cells with well-separated nuclei are counted, as opposed to counting all binucleated
cells with non-overlapping nuclei, significantly increases the frequency of bridges
observed. Regardless of the scoring method used, statistically significant associations
among micronuclei, bridges, and buds have been demonstrated in the work described
here.

42
REFERENCES
1.

Fenech, M., The lymphocyte cytokinesis-block micronucleus cytome assay and
its application in radiation biodosimetry. Health Phys, 2010. 98(2): p. 234-43.

2.

Kirsch-Volders, M., et al., The in vitro MN assay in 2011: origin and fate,
biological

significance,

protocols,

high

throughput

methodologies

and

toxicological relevance. Arch Toxicol, 2011. 85(8): p. 873-99.
3.

Shimizu, N., Molecular mechanisms of the origin of micronuclei from
extrachromosomal elements. Mutagenesis, 2011. 26(1): p. 119-23.

4.

Hoffelder, D.R., et al., Resolution of anaphase bridges in cancer cells.
Chromosoma, 2004. 112(8): p. 389-97.

5.

Eastmond, D.A. and J.D. Tucker, Identification of aneuploidy-inducing agents
using cytokinesis-blocked human lymphocytes and an antikinetochore antibody.
Environ Mol Mutagen, 1989. 13(1): p. 34-43.

6.

Fenech, M. and A.A. Morley, Kinetochore detection in micronuclei: an alternative
method for measuring chromosome loss. Mutagenesis, 1989. 4(2): p. 98-104.

7.

Vral, A., H. Thierens, and L. De Ridder, In vitro micronucleus-centromere assay
to detect radiation-damage induced by low doses in human lymphocytes. Int J
Radiat Biol, 1997. 71(1): p. 61-8.

8.

Fenech, M., et al., Molecular mechanisms of micronucleus, nucleoplasmic bridge
and nuclear bud formation in mammalian and human cells. Mutagenesis, 2011.
26(1): p. 125-32.

9.

Murnane, J.P., Telomere dysfunction and chromosome instability. Mutation
research, 2012. 730(1-2): p. 28-36.

43
10.

Thomas, P., K. Umegaki, and M. Fenech, Nucleoplasmic bridges are a sensitive
measure of chromosome rearrangement in the cytokinesis-block micronucleus
assay. Mutagenesis, 2003. 18(2): p. 187-94.

11.

Crott, J.W., et al., The effect of folic acid deficiency and MTHFR C677T
polymorphism on chromosome damage in human lymphocytes in vitro. Cancer
Epidemiology, Biomarkers & Prevention, 2001. 10(10): p. 1089-96.

12.

Fenech, M. and J.W. Crott, Micronuclei, nucleoplasmic bridges and nuclear buds
induced in folic acid deficient human lymphocytes-evidence for breakage-fusionbridge cycles in the cytokinesis-block micronucleus assay. Mutation Research,
2002. 504(1-2): p. 131-6.

13.

Utani, K., A. Okamoto, and N. Shimizu, Generation of micronuclei during
interphase by coupling between cytoplasmic membrane blebbing and nuclear
budding. PLoS One, 2011. 6(11): p. e27233.

14.

Utani, K., et al., Emergence of micronuclei and their effects on the fate of cells
under replication stress. PLoS One, 2010. 5(4): p. e10089.

15.

Serrano-Garcia, L. and R. Montero-Montoya, Micronuclei and chromatid buds are
the result of related genotoxic events. Environ Mol Mutagen, 2001. 38(1): p. 3845.

16.

Fenech, M. and A.A. Morley, Measurement of micronuclei in lymphocytes. Mutat
Res, 1985. 147(1-2): p. 29-36.

17.

Hovhannisyan, G., R. Aroutiounian, and T. Liehr, Chromosomal composition of
micronuclei in human leukocytes exposed to mitomycin C. J Histochem
Cytochem, 2012. 60(4): p. 316-22.

44
18.

Asur, R.S., R.A. Thomas, and J.D. Tucker, Chemical induction of the bystander
effect in normal human lymphoblastoid cells. Mutat Res, 2009. 676(1-2): p. 11-6.

19.

Fenech, M., et al., HUMN project: detailed description of the scoring criteria for
the cytokinesis-block micronucleus assay using isolated human lymphocyte
cultures. Mutation Research, 2003. 534(1-2): p. 65-75.

20.

Fenech, M., Cytokinesis-block micronucleus cytome assay. Nature Protocols,
2007. 2(5): p. 1084-104.

21.

Woolf, B., On estimating the relation between blood group and disease. Ann
Hum Genet, 1955. 19(4): p. 251-3.

22.

Mantel, N. and W. Haenszel, Statistical aspects of the analysis of data from
retrospective studies of disease. J Natl Cancer Inst, 1959. 22(4): p. 719-48.

23.

Rajendran, S., et al., The role of mitochondria in the radiation-induced bystander
effect in human lymphoblastoid cells. Radiat Res, 2011. 175(2): p. 159-71.

24.

McClintock, B., The Stability of Broken Ends of Chromosomes in Zea Mays.
Genetics, 1941. 26(2): p. 234-82.

25.

Pawlik, T.M. and K. Keyomarsi, Role of cell cycle in mediating sensitivity to
radiotherapy. Int J Radiat Oncol Biol Phys, 2004. 59(4): p. 928-42.

45
CHAPTER 3
This chapter has been published in the journal "PLOS ONE". The citation of this
paper is:
Seth, I., Schwartz, J.L., Stewart, R.D., Emery, R., Joiner, M.C., Tucker, J.D. (2014)
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effectiveness, PLOS ONE Vol 9 (6): e98947.
Neutron exposures in human cells: bystander effect and relative biological
effectiveness

INTRODUCTION
Ionizing radiation leads to chromosome damage of the type seen in cancer cells.
Ionizing radiation is also an effective method for treating tumors because it can be
localized to the tumor and is a potent inducer of DNA double-strand breaks, a highly
toxic form of DNA damage. While much has been learned about x-ray and gamma-ray
effects on cells and whole organisms, less is known about the biological effects of
neutrons. Neutrons are highly energetic uncharged particles that induce more severe
DNA damage than photons and are therefore more effective than photons in controlling
radioresistant tumors. The relative biological effectiveness (RBE) of neutrons has been
reported to be as low as 1 and perhaps higher than 10 depending on the tissue type,
neutron energy and the biological endpoint being measured [1]. Neutrons were listed as
a carcinogen for the first time in the Eleventh Report on Carcinogens [2]. High levels of
neutron irradiation occur in patients receiving neutron therapy, while low levels of
neutron exposure occur in patients treated with high energy photons and protons. Other
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sources of low level neutron irradiation may include occupational exposure to workers at
nuclear power plants and accelerator facilities, astronauts, airline crews and passengers
on high altitude flights [3-14], as well as radiation incidents such as the HiroshimaNagasaki atomic bomb explosions and the tsunami-induced radiation leak at the
Fukushima Daiichi site in Japan [15].
One of the major paradigm shifts in the field of radiation biology was the
discovery of non-targeted effects such as the bystander effect in which cells in the
vicinity of radiation-damaged cells behave as though they were also irradiated [16-20].
In addition, late effects such as chromosomal instability may increase susceptibility to
cancer [21]. Thus, cells that are directly damaged are not the sole targets of radiation
exposure. Cells that do not absorb radiation directly may nevertheless be damaged or
altered in ways that do not become apparent for many cell generations. Such nontargeted effects may have serious implications for human health and may cause cancer.
Therefore, the risks of ionizing radiation need to be analyzed in terms of both direct and
non-targeted effects.
The bystander effect has been observed repeatedly in mammalian cell lines,
including human skin fibroblasts, epithelial cells and leukemic cells in response to
ionizing photons [17,22-36]. Depending upon the cell and tissue type, bystander signals
can be transmitted either through the culture medium [17] or by cell-to-cell contact
including gap junctional communication [37]. Some of the candidate intercellular
signaling molecules that have been implicated in bystander effects are reactive oxygen
species [20,38], reactive nitrogen species [20,38], nitric oxide [27,38], cytokines such as
TGFβ and interleukin 8 [39], and small molecules such as amino acids [37,40,41]. The
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involvement of intracellular signaling molecules including mitogen-activated protein
kinases (MAPK) and their downstream proteins [42,43], protein kinase C (PKC)
isoforms [44], tumor protein 53 (p53) [45,46], cyclin-dependent kinase inhibitor 1A
(CDKN1A, p21) [47], ataxia telangiectasia mutated protein (ATM) [44], and ataxia
telangiectasia and Rad3 related (ATR) DNA-dependent protein kinase (DNA-PK)
[44,48] have also been implicated. Recently, some laboratories have suggested that the
presence of serotonin in the serum is one of the key factors involved in the bystander
effect [49-51], however this finding has been disputed [52].
Most bystander effect studies have been performed using x-rays [22,24,29],
gamma rays [17,35,53] and alpha particles [47,54,55], however, little has been done
concerning the effects of neutron radiation [56]. Such information might be important for
risk estimation in response to neutron exposure. No conclusive cytogenetic evidence
exists to support or refute the existence of non-targeted effects in cellular responses to
neutrons. A bystander effect following neutron exposure has been observed in Chinese
hamster ovary cells [57], but no effect was seen in zebrafish irradiated in vivo [56].
There are no available cytogenetic data concerning the bystander effect in human cells
in response to neutrons.
Here we used the cytokinesis-block micronucleus assay to address the question
whether neutrons induce a bystander effect in normal human lymphoblastoid cell lines.
We also assessed the RBE of fast neutrons produced by 50.5 MeV protons incident on
a Be target (~17 MeV average neutron energy) compared to cobalt-60 gamma radiation.
For the endpoints of micronuclei and nucleoplasmic bridges, we found no evidence to
indicate that neutrons induce a bystander effect in normal human lymphoblastoid cells.
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The measurements indicate that the neutron RBE for directly damaged cells compared
to cobalt-60 gamma rays is 2.0 ± 0.13 for micronuclei and 5.8 ± 2.9 for bridges.
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MATERIALS AND METHODS
Cell lines
Normal human lymphoblastoid cell lines (GM15036 and GM15510) obtained from
the Coriell Cell Repository were used for these experiments because they have
previously been shown to exhibit a bystander effect in response to gamma radiation
[22,24].

Cell culture
Cell culture was performed using the standardized protocol provided by Coriell.
The serum used in this study was prescreened for its ability to support a bystander
effect with the cytokinesis-block micronucleus assay in these same cell lines. Since
serotonin has been reported to play a role in the bystander effect [49] and is light
sensitive, the bottles containing the culture media were wrapped in aluminum foil and
stored in the dark. Cells were cultured and grown in suspension in non-vented T-25
flasks with loosened caps (Corning, NY and ISC BioExpress, Kaysville, UT) containing
10 ml of medium consisting of RPMI1640 (GIBCO, Grand Island, NY or Hyclone, Logan,
UT) supplemented with 15% Fetal Bovine Serum (FBS, Atlanta Biologicals,
Lawrenceville, GA), 2 mM L-glutamine (GIBCO, Grand Island, NY), penicillinstreptomycin (100 units/ml penicillin G Sodium, 100 µg/ml Streptomycin sulfate in 0.85%
saline; GIBCO, Grand Island, NY), fungizone (amphotericin B, 2.5 µg/ml, 0.2 µm
filtered; Hyclone, Logan, UT). All cultures were grown and maintained in a fully
humidified 5% CO2 incubator at 37°C. Approximately every 3 days the cells were
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counted and passaged by seeding at a concentration of 3x10 5 cells/ml. Cell culture for
all the gamma radiation experiments was performed at Wayne State University (WSU),
Detroit, Michigan. For the neutron radiation experiments, cells were grown at WSU up to
a concentration of 1x106 cells/mL, then non-vented T-25 flasks were completely filled
with media (60 ml) containing cells at this concentration. Two flasks per cell line were
then shipped overnight to the University of Washington Medical Center (UWMC),
Seattle. Upon arrival, the flasks were immediately placed upright in a fully humidified 5%
CO2 incubator at 37°C, and their caps were loosened. The flasks were left undisturbed
for 24 hours after which the cells were counted and checked for viability using a
hemocytometer and trypan blue staining. Cells were then passaged once and cultured
as described above.

Radiation exposures
All neutron irradiations were carried out using the fast clinical neutron therapy
system (CNTS) at the University of Washington (Seattle, WA). All gamma irradiations
were performed in the Gershenson Radiation Oncology Center, WSU. For neutron
irradiations, the cells in culture medium in T-25 flasks were irradiated at room
temperature with doses 0 (sham), 0.5, 1, 1.5, 2, 3 and 4 Gy. The CNTS generates fast
neutrons by targeting a near monoenergetic 50.5 MeV proton beam at a Be target (10.5
mm thick with a radius of 0.635 cm). The neutron beam is shaped by a primary
collimator composed of iron and a secondary collimator made up of individually movable
leaves composed of iron with cylindrical polyethylene inserts. Cells in T-25 flasks with
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culture medium were placed on top of 2 cm of water-equivalent material and irradiated
at 0.6 Gy/min from below (gantry at 180 degree) using an open 28.8 x 28.8 cm 2 field
(SSD of 148 cm). The average energy and neutron mean free path varies with field size
and water-equivalent depth (nominal depth of maximum dose is 1.5 cm). For
experiments reported in this work, the average neutron energy is about 17 MeV, and the
neutron mean free path in water is about 9 cm. For every dose, two flasks were
irradiated per cell line: one flask was used to assess the damage induced by direct
radiation exposure and the other flask was used for medium transfer for the bystander
effect as described below. For the direct damage and the bystander effect experiments,
three different controls were used: pre-radiation, post-radiation, and transportation
control. Pre-radiation and post-radiation control flasks were sham-irradiated with
exposure times corresponding to the lowest (0.5 Gy) and the highest (4 Gy) neutron
dose, respectively. The transportation control involved flasks that were transported with
the cells that were irradiated, but remained inside the insulated box; these control flasks
were further insulated with bubble wrap to maintain their temperature close to 37°C.
This box was the same as that used to carry the flasks to and from the laboratory and
the radiation center (a 2 minute walk). For the bystander effect an additional media-only
control was included; these flasks contained fresh, complete, culture media without any
cells and were irradiated at the highest dose, i.e. 4 Gy. Media from these flasks was
transferred to non-irradiated cells in the same manner as described for media transfer
from flasks that contained cells. Following exposure the flasks were returned
immediately to the laboratory and incubated for 28 hours. The cells were then harvested
as described below. For each cell line, the neutron bystander experiment was
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performed twice, once each on different days. Replicate 2 had all the controls as
described for replicate 1 except the transportation control was not included.
The Be target system used to generate fast neutrons also delivers a photon dose
of about 5% of the neutron dose, which raises the possibility that any bystander effect
observed in the experiments could be due to photons rather than to the neutrons. To
rule out this possibility, cells were acutely irradiated with cobalt-60 gamma rays at doses
equivalent to the 5% of the delivered neutron dose, i.e. 0 (sham), 0.025, 0.05, 0.075,
0.10, 0.15 and 0.20 Gy. We also included a media-only control containing fresh media
without cells, which was irradiated at the highest dose, i.e. 0.2 Gy.
As a positive control for the bystander effect, cells were exposed to 0 (sham),
0.5, 1, 2, 3 and 4 Gy cobalt-60 gamma rays. To ensure that the bystander effect
observed was actually due to signals produced by the irradiated cells rather than an
effect of exposure of the culture medium or an artifact of the media transfer process, a
media-only control was included in which fresh media without cells was irradiated at the
highest dose (4 Gy) prior to being transferred to non-irradiated cells. For the gamma
radiation experiments, flasks were transported to and from the laboratory and the
radiation center, a 5-minute car ride, in an insulated container as described above.

Assessment of direct radiation damage
To assess the effects of direct radiation damage on these cells, Cytochalasin B
(6 µg/ml final concentration; Sigma, St. Louis, MO) dissolved in DMSO (Fisher
Scientific, Pittsburg, PA) was added four hours after irradiation to directly-irradiated cells
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to block cytokinesis. The final concentration of DMSO in each culture was 1.1%. The
cell cultures were then incubated at 37°C for 28 hours.

Media transfer
Following irradiation, the cells were left undisturbed until media transfer, which
was performed four hours after irradiation as previously described [17]. Briefly, the cell
cultures from the non-irradiated and irradiated flasks were transferred to 15 ml
centrifuge tubes (Nalgene Nunc International, Rochester, NY) and centrifuged at 370 x
g for 5 minutes. To ensure that no cells were transferred along with the media, the
supernatant was then passed through 0.22 µm polyethylsulfonate syringe filters
(Nalgene). The media from the irradiated cells contains factors secreted by the
irradiated cells and hence is considered to be “conditioned”. The media from the nonirradiated (bystander) cells was gently removed by aspiration and replaced with
conditioned media. The non-irradiated cells in the conditioned media were then
transferred to new T-25 culture flasks and immediately after media transfer 6 µg/ml
(final concentration) of Cytochalasin B was added to each culture to block cytokinesis.
The cell cultures were then incubated at 37°C for 28 hours.

Micronucleus Assay - Cell harvesting and slide preparation
Twenty-eight hours following media transfer, the cultures were swirled and
pipetted gently to resuspend and break up the clumps of cells. Cells that were directly
irradiated as well as those treated with conditioned media were centrifuged onto
ethanol-cleaned microscope slides for 4 minutes at 93 x g using a cytocentrifuge
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(Statspin, Westwood, MA). The slides were air-dried, fixed in 100% methanol (Fisher
Scientific Pittsburgh, PA) for 15 minutes, and then stained with 100 μl of acridine orange
(0.5 mg/ml in 1X PBS) (Allied Chemical Corporation, Morristown, NJ) for 1 minute in the
dark. The excess stain was removed by washing in 1X PBS for 1 minute. The slides
were then mounted with 1X PBS and 25 x 25 mm2 glass coverslips.

Micronuclei scoring criteria
All slides were coded prior to scoring to prevent observer bias. The Nuclear
Division Index (NDI) for each dose and treatment was determined by evaluating at least
200 cells and determined according to the following formula:
NDI = [(M1 + ( 2 x M2) + (3 x M3) + (4 x M4)) / N]
where M1-M4 represent the number of cells with one to four nuclei, respectively, and N
is the total number of cells scored [75]. Calculation of the NDI was important to ensure
that the number of binucleated cells was sufficient for enumerating micronuclei.
Cells were then evaluated simultaneously for micronuclei, nucleoplasmic bridges
and buds according to our “relaxed” criteria [76]. Briefly, only binucleated cells with nonoverlapping nuclei were evaluated. Micronuclei were required to be no more than onethird the size of the nuclei, and to be round or oval with smooth edges and stained the
same color as the nuclei. Bridges were required to span the entire distance between the
two nuclei. Buds were counted only if the stalk was thinner than the widest part of the
bud. Since buds did not exhibit a consistent response for either cell line in any of the
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experiments, we have not included these data in this paper. For each treatment
condition, at least 1000 binucleated cells were scored by trained observers. For any
experiment, either one observer evaluated all the treatment conditions or the scoring
was balanced between two observers such that each evaluated approximately equal
numbers of cells for each treatment condition.

Statistical Analyses
Analysis of variance (ANOVA) was performed to evaluate radiation-induced dose
responses in cells directly irradiated with neutrons or high doses of photons, and in cells
treated with ICCM from these irradiated cells. For each experiment, the independent
variables considered were cell line, dose, and the interaction between cell line and
dose. The dependent variables were micronuclei and bridges. The same set of analyses
were performed for the neutron bystander data which included replicate experiments as
an additional variable. The Tukey HSD test was used for post-hoc evaluations. These
analyses were performed using JMP software version 6.0, SAS Institute Inc. Chi
squared analyses were used to evaluate changes in the frequencies of micronuclei and
bridges in the irradiated cells as a pooled group compared to the unirradiated (0-dose
control) cells for the high dose photon experiments, and for the low dose photon
contamination experiments.
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RESULTS
Nuclear Division Indices
The Nuclear Division Indices (NDI) for all experimental conditions were high
enough to enumerate micronuclei and bridges, with the exception of cells irradiated with
the highest two neutron doses (3 Gy and 4 Gy). Here, radiation-induced cell cycle
delays precluded obtaining sufficient numbers of scoreable binucleated cells (Table 1).
Although these cells had NDI values similar to the 3 Gy and 4 Gy photon-irradiated
cells, they could not be scored because their morphology was not compatible with
accurate damage assessments. NDI’s for the two replicate neutron bystander
experiments were very similar (p > 0.05).
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Table 3.1. Average number of nuclei per cell in directly exposed and
bystander cells for neutron and cobalt-60 gamma rays.
Radiation dose
(Gy)

Nuclear division index
GM15510 cells
Direct
Bystandera

Neutrons
0 (pooled)b

GM15036 cells
Direct
Bystandera

2.27

2.11

1.98

2.11

4 (media only)c

-

2.23

-

2.09

0.5
1
1.5
2
3

1.61
1.46
1.35
1.24
1.20d

2.20
2.06
1.90
2.18
2.07

1.39
1.40
1.25
1.18
1.14d

2.00
1.98
2.33
1.93
2.13

4

1.11d

2.30

1.09d

2.14

1.92
1.87
1.64
1.24
1.13
1.06

1.79
1.97
1.89
1.92
1.82
1.92
1.90

1.79
1.58
1.51
1.21
1.19
1.13

1.71
1.83
1.79
1.93
1.81
1.82
1.85

Cobalt-60 γ
0
4 (media only)c
0.5
1
2
3
4
a

Neutron data shown are for replicate 1; the values for replicate 2
were similar (p > 0.05).
b
Combined values of the controls (pre-radiation, post-radiation and
transportation control).
c
Media without cells was irradiated with 4 Gy and transferred to
unirradiated cells.
d

Too few high quality binucleated cells were available for scoring.
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Direct damage induced by neutrons
For both cell lines, direct irradiation with neutrons resulted in clear doseresponsive increases in the number of micronuclei (Figure 3.1a) and nucleoplasmic
bridges (Figure 3.1b) per 1000 binucleated cells. Since the three 0-dose controls (i.e.,
pre-radiation, post-radiation, and transportation control) for micronuclei and for
nucleoplasmic bridges were not statistically different from each other as determined by
ANOVA, we report only the pooled control values for these endpoints.
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Figure 3.1 Micronuclei (a) and nucleoplasmic bridges (b) per 1000 binucleated cells in
normal human lymphoblastoid cells directly irradiated with neutrons. Vertical lines
represent the 95% confidence intervals.
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Lack of bystander effect in response to neutrons
Cells treated with ICCM from neutron irradiated cells did not show significant
increases in micronuclei frequencies compared to sham treated controls for either
replicate experiment and for either cell line (Figure 3.2). As expected, the media-only
control and the 0 Gy control were not statistically different (p > 0.05). For GM15510
cells, although the micronuclei frequencies show substantial variation, there clearly is
not any consistent evidence of a bystander effect. GM15036 cells that received ICCM
from any dose greater than 0 had frequencies of micronuclei that were similar to each
other, and all were lower than the 0-dose values, although the differences were not
statistically significant. The frequencies of nucleoplasmic bridges (Figure 3.2b) showed
considerable variation and no consistent dose-related response was seen for either cell
line. For both cell lines and for both end-points, i.e. micronuclei and nucleoplasmic
bridges, compared to the controls no treatment condition caused any statistically
significant change in the frequencies for either of the replicate experiments (p > 0.05).
These data indicate that neutrons do not induce a bystander effect in these cell lines
under these experimental conditions.
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Figure 3.2 Micronuclei (a) and nucleoplasmic bridges (b) per 1000 binucleated cells in
normal human lymphoblastoid cells cultured in conditioned media from neutron
irradiated cells. For each treatment (i.e., cell line and dose group) the left-hand bar in
each pair is replicate 1 and the right-hand bar is replicate 2. The 1 Gy data are missing
for GM15510 cells replicate 2 because the sample was lost. Vertical lines represent the
95% confidence intervals.
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No bystander effect observed due to photon contamination
The neutron beam used in these experiments is contaminated with photons at a
level of approximately 5%. Even though a bystander effect was not observed with the
neutron exposures, we sought to determine whether photons might cause a bystander
effect at the doses employed in these experiments. We cultured GM15510 and
GM15036 cells in ICCM obtained from the corresponding cell line that had been
irradiated with cobalt-60 at doses equivalent to 5% of the neutron doses. The results,
shown in Figure 3.3, indicate that these low doses of photons did not produce a
bystander effect. As a pooled group, cells grown in ICCM showed no significant
increase in the frequencies of micronuclei or bridges compared to cells grown in
conditioned media from unirradiated cells, as determined by Chi-squared analyses. The
media-only control had values similar to the 0 Gy (control) for both endpoints.
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Figure 3.3 Micronuclei (a) and nucleoplasmic bridges (b) per 1000 binucleated cells in
normal human lymphoblastoid cells treated with conditioned media from cells that were
directly irradiated with cobalt-60 γ-radiation at doses equivalent to 5% of the neutron
doses. Vertical lines represent the 95% confidence intervals.
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Positive control experiment: Direct damage induced by high doses of cobalt-60 gamma
rays
To reaffirm that the experimental conditions used here are capable of seeing a
direct (i.e. non-bystander) effect of gamma ray exposure, experiments identical to those
performed with neutrons were carried out with high doses of cobalt-60. Direct exposure
to these photons with doses from 0 to 4 Gy showed a clear dose responsive increase in
the number of micronuclei and the number of bridges per 1000 binucleated cells for
both cell lines (Figure 3.4). The frequencies of micronuclei and bridges appear to
saturate at higher doses, indicating that multiple chromosome fragments were
packaged in some micronuclei, and that more than one dicentric might have contributed
to some bridges. The increases for both micronuclei and bridges with dose were
significant with and without considering the 4 Gy data point (p < 0.0001).
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Figure 3.4 Micronuclei (a) and nucleoplasmic bridges (b) per 1000 binucleated cells in
normal human lymphoblastoid cells directly irradiated with high doses of cobalt-60 γradiation gamma rays. Vertical lines represent the 95% confidence intervals.
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Bystander effect induced by high doses of cobalt-60 gamma rays
Photons have been known to induce bystander effects in human cells for many
years. However, since the neutron exposures and the low-dose photon exposures did
not induce a bystander effect, it was important to verify that the cells and the
experimental conditions in these experiments, including the serum used in the culture
media, are capable of demonstrating a bystander effect if one exists. As expected,
GM15510 and GM15036 cells cultured in ICCM obtained from cells exposed to high
doses of cobalt-60 gamma rays showed a 2 to 3 fold increase in micronuclei
frequencies compared to sham treated controls, clearly indicating induction of a
bystander effect (Figure 3.5a). Compared to cells grown in conditioned media from
unirradiated cells, as a pooled group all 6 ICCM cultures for each cell line showed
increases in micronuclei (p < 0.0001). Nucleoplasmic bridges (Figure 3.5b) showed a
weak bystander effect for GM15510 (p = 0.052), and for GM15036 the effect was highly
significant (p < 0.0001).
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Figure 3.5 Micronuclei (a) and nucleoplasmic bridges (b) per 1000 binucleated cells in
normal human lymphoblastoid cells cultured in conditioned media from cobalt-60 γirradiated cells. No bridges were observed in the 4 Gy sample for GM15510 cells, or for
the media only samples for either cell line. Vertical lines represent the 95% confidence
intervals.
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Bystander component of the total dose response of cobalt-60 gamma rays and neutrons
If the mechanisms of action for direct and non-targeted damage are independent,
the total cellular response to ionizing radiation is the sum of the direct and the indirect
exposure effects. The bystander components in the total dose response of cobalt-60
gamma rays ranged from approximately 4% to 35% for micronuclei; for bridges, the
bystander components ranged up to 6% for GM15510 cells and up to 23% for GM15036
cells (Tables 2 and 3). In contrast, there was no statistically significant bystander
component for neutrons (data not shown).
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Table 3.2. Percent contribution of the bystander effect to the total direct exposure
effect in cobalt-60 irradiated cells for micronuclei.
Cobalt-60
gamma dose
(Gy)

Micronuclei/1000
binucleated cells
Direct
exposure

GM15510 cells
0
0.5
1.0
2.0
3.0
4.0
GM15036 cells
0
0.5
1.0
2.0
3.0
4.0
a

Bystander
exposure

Micronuclei induceda
% bystander
component b
Direct
exposure

Bystander
exposure

15.0
136.0
262.0
396.0
688.0
583.0

15.9
29.9
31.9
32.9
47.0
37.8

0.0
121.0
247.0
381.0
673.0
568.0

0.0
14.0
16.0
17.0
31.1
21.9

11.6
6.5
4.5
4.6
3.9

45.0
169.0
237.0
327.0
375.0
359.0

28.5
72.2
74.6
49.6
58.4
59.0

0.0
124.0
192.0
282.0
330.0
314.0

0.0
43.7
46.2
21.1
30.0
30.5

35.3
24.0
7.5
9.1
9.7

Number of micronuclei per 1000 binucleated cells after subtracting the baseline (0
dose) values for that cell line.
b
Percent of the induced total direct exposure response that can be attributed to the
induced bystander effect.
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Table 3.3. Percent contribution of the bystander effect to the total direct exposure
effect in cobalt-60 irradiated cells for nucleoplasmic bridges.
Cobalt-60
gamma dose
(Gy)

Bridges/1000
binucleated cells

Bridges induceda
% bystander
component b

Direct
exposure

Bystander
exposure

Direct
exposure

Bystander
exposure

GM15510 cells
0
0.5
1.0
2.0

12.0
14.0
25.0
61.0

2.0
2.0
2.0
1.0

0.0
2.0
13.0
49.0

0.0
0.0
0.0
-1.0

3.0
4.0

96.0
96.0

6.9
0.0

84.0
84.0

4.9
-2.0

0.2
0.0
⁻c
5.8
⁻c

GM15036 cells
0
0.5
1.0
2.0
3.0
4.0

5.0
37.0
38.0
43.0
60.0
55.0

2.0
4.0
8.0
6.9
6.9
8.0

0.0
25.0
26.0
31.0
48.0
43.0

0.0
2.0
6.0
4.9
4.9
6.0

7.9
23.0
16.0
10.3
14.0

a

Number of bridges per 1000 binucleated cells after subtracting the baseline (0
dose) values for that cell line.
b
Percent of the induced total direct exposure response that can be attributed to the
induced bystander effect.
c
Percent bystander component could not be evaluated because the induced
bystander effect is negative.
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Relative biological effectiveness (RBE) of the UW CNTS Fast Neutrons
RBE is the ratio of doses that achieve the same biological effect for two radiation
types. When the biological responses for both radiation types are linearly related to
dose, as seen here, the RBE is also the ratio of the biological effects at the same dose.
Here, the neutron RBE was calculated relative to cobalt-60 gamma rays by dividing the
frequencies of micronuclei and bridges obtained in cells irradiated directly with neutrons
at each dose to the frequencies obtained in cells irradiated directly with photons at the
same dose. The RBE of neutrons for all doses and both cell lines is 2.0 ± 0.13 for
micronuclei and 5.8 ± 2.9 for bridges (Table 4), indicating that neutrons are 2 to nearly 6
times more effective in damaging these cells compared to cobalt-60 gamma rays.
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Table 3.4. Relative biological effectiveness for neutrons relative to cobalt-60 gamma
rays for micronuclei and nucleoplasmic bridges.

Dose (in Gy)

GM15510 cells
0
0.5
1.0
2.0
GM15036 cells
0

Induceda
micronuclei/1000
binucleated cells
Cobalt-60
gamma
rays

Neutrons

0.0

0c

121.0
247.0
381.0

255.0
551.4
718.8

0.0

0c

0.5
124.0
1.0
192.0
2.0
282.0
mean +/- S.E. both cell lines

173.0
427.9
599.3

RBE

b

Induceda
bridges/1000
binucleated cells

RBEb

Cobalt Neutrons
-60
gamm
a rays

2.1
2.2
1.9

1.4
2.2
2.1
2.0 ± 0.13

0.0

0c

2.0
13.0
49.0

40.0
66.9
99.7

0.0

0c

32.0
33.0
38.0

32.8
112.0
113.3

20.0
5.1
2.0

1.0
3.4
3.0
5.8 ± 2.9

a

The number of micronuclei or bridges per 1000 binucleated cells after subtracting the
baseline (0 dose) values, which were 15.0 and 45.0 for micronuclei and 12.0 and 5.0
for bridges for cobalt-60 gamma for GM15510 and GM15036 cells, respectively. For
neutrons the baseline values were 28.0 and 29.1 for micronuclei and 2.0 and 11.6 for
bridges for GM15510 and GM15036 cells, respectively.
b
c

Relative biological effectiveness: neutrons / cobalt-60 gamma rays.

Combined values of the controls (pre-radiation, post-radiation and transportation
control).

73
DISCUSSION

The experiments described here provide no cytogenetic evidence that fast
neutrons are capable of inducing a bystander effect through medium-borne factors. The
neutron beam used in these experiments was contaminated with photons, necessitating
parallel evaluations to determine whether there is a positive or an inhibitory effect of
these photons on the results of the neutron experiments. Our observation of an absence
of a bystander effect following doses of photons that are associated with exposure to
neutrons confirmed that there is a lack of a bystander effect in response to neutrons,
regardless of the presence of photons. Wang et al. [56] have suggested that neutrons
might suppress gamma ray-induced bystander signaling. They measured apoptosis and
cell survival in zebrafish that received bystander signals from fish that were directly
irradiated with neutrons. Since the doses of photons that contaminated these neutron
exposures exceeded the minimum threshold for inducing a bystander effect [29,58],
Wang et al. [56] suggested that the gamma ray-induced bystander effect might have
been suppressed by the neutron exposures. With our data it is difficult to determine
whether neutrons have the ability to suppress any bystander effect produced by
photons because a source of uncontaminated neutrons is not available. The results
shown here suggest that contaminating photons are not a likely confounding factor that
interfered with the ability to detect a neutron-induced bystander effect.
Different responses to neutrons were observed in the two cell lines we used.
GM15510 cells cultured in ICCM from neutron irradiated cells showed substantial
variation in micronuclei frequencies but no consistent dose-related response. In
contrast, GM15036 cells had micronuclei frequencies lower than the corresponding 0-
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dose control value, although the control value was well within the historical range for
this cell line. Although we did not measure apoptosis or necrosis, these outcomes may
influence the responses seen in these cell lines.
There is clear evidence of a bystander effect in response to high doses of
photons when we used the same serum and cell lines as for the neutron experiments.
This result indicates that the methods used in our study are capable of detecting a
bystander effect if such an effect exists. To the best of our knowledge there is no other
factor that could have prevented neutrons from inducing a bystander effect in these
cells, assuming a bystander effect even exists. Our findings are in agreement with
previous studies that have reported the lack of a bystander effect on neutron exposure
using clonogenic cell survival assay in a human skin cell line [29] and zebrafish [56].
However, other studies have reported contrasting results. Watson et al. [59] found that
transplantation of a mixture of neutron irradiated and unirradiated bone marrow cells
into mice induced instability in the descendants of unirradiated cells as confirmed by
measuring chromosomal aberrations, indicating that neutrons induce a bystander effect.
However, since the gamma component in neutrons was 25%, it is possible that the
observed bystander effect was due to the contaminating photons, which the authors did
not rule out. Kinashi et al. [57] studied a neutron-induced bystander effect in boron
neutron capture therapy with a cell survival assay as well as cloning and sequencing
methods. They reported an increase in the frequency of mutations in the hypoxanthineguanine phosphoribosyltransferase locus in cells located near the irradiated cells.
These results suggest that a neutron bystander effect may be comprised of gene
mutations.
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The inability of fast neutrons to induce a cytogenetic bystander effect as shown
here may be due to different types of damage induced at the molecular level compared
to photons. Cellular recognition of DNA damage and the subsequent repair processes
may differ between neutrons and photons. Furthermore, due to the lower levels of
oxidative damage and free radical production by neutrons compared to photons [60],
some of the critical bystander signaling pathways may not be activated. There is also
the possibility that a neutron-induced bystander effect, if any, might depend on cell type,
the endpoint being evaluated [61,62], and the energy of the neutrons.
Neutrons, depending on their energy, might be more effective in controlling
certain tumor types where conventional photon therapy is ineffective [63] because the
oxygen enhancement ratio, i.e. the differential radiosensitivity between poorly
oxygenated (more resistant) and well-oxygenated (more sensitive) cells, is reduced with
neutrons. Unlike low-LET radiation, for high-LET radiation there is also a reduction in
the differential radiosensitivity of cells related to their position in cell cycle [60]. Recently,
radiation-induced bystander cells were shown to rescue irradiated cells through
intercellular feedback. Chen et al. [40] observed a significant decrease in the number of
DNA double-strand breaks, micronuclei frequencies, and the extent of apoptosis in
irradiated cells that were co-cultured with unirradiated bystander cells. Observation of
an absence of a bystander effect in the present study may help explain the sensitivity of
radioresistant tumor cells to neutrons, because there is a possibility that the protection
otherwise provided by the bystander effect on the tumor in response to neutrons is
absent or not strong enough in magnitude, thereby causing tumor cells to be killed. The
risks currently associated with neutron exposure may be over or underestimated
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depending on which model of risk estimation is used to predict low dose risks from high
dose data. Hence, reevaluation of radiation protection standards may be required. The
work described in this paper may be relevant for radiation oncologists planning cancer
treatments that involve fast neutron or proton radiotherapy, particularly for pediatric
patients or pregnant women.
This study used cells that lack gap junctions. There is a possibility that a neutroninduced bystander effect requires physical contact between cells, which could be tested
by performing experiments using cell lines such as fibroblasts and keratinocytes that
have gap junctions. If no bystander effect is induced in these cell lines, then it may be
likely that neutrons do not have any ability to induce a bystander effect. Another
possible explanation for the lack of a bystander effect with neutrons observed in this
study may be the presence of dimethyl sulfoxide (DMSO), a scavenger of reactive
oxygen species [64,65], which was used to dissolve cytochalasin B that is required for
the cytokinesis-block micronucleus assay. Both pre- and post-radiation treatment with
DMSO is known to suppress DNA damage in irradiated cells [66]. However, this
possibility seems unlikely in the work described here because we observed a bystander
effect with an identical procedure involving DMSO when the same cell lines were
exposed to photons. However, if a very small bystander effect was in fact induced by
neutrons, then it may have been obscured by the DMSO, whereas the bystander effect
induced by high levels of photons was too large to be masked by DMSO.
For cells irradiated with high doses of photons, a considerable amount of
damage was attributed to the bystander component. The percent contribution by the
bystander exposure to the direct exposure was highest at the lowest dose delivered (0.5
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Gy) and then it appears to saturate as dose increases, perhaps because there is
saturation either of the bystander signals or the cellular responses to those signals [67].
This observation is in agreement with other reports [55,68,69]. For cells irradiated with
neutrons there is little or no damage that can be attributed to a bystander effect,
because as previously noted, there is comparatively less oxidative damage following
neutron than gamma exposure.
We report two RBEs for neutron radiation, one for micronuclei and the other for
nucleoplasmic bridges. These two genetic endpoints have different mechanisms of
formation. Micronuclei are formed from lagging chromosomes and acentric fragments at
anaphase, while nucleoplasmic bridges are formed when centromeres of dicentric
chromosomes are pulled in opposite directions during mitosis [70]. RBEs of 2.0 ± 0.13
for micronuclei and 5.8 ± 2.9 for nucleoplasmic bridges relative to cobalt-60 suggest that
different kinds of genetic damage may be associated with different RBEs. RBE values
are known to depend on factors such as linear energy transfer, tissue type, the extent of
biological damage, and dose [60]. Knowing the RBE is important for radiation
oncologists to determine the dose prescription and the most effective radiotherapy
treatment plan for cancer patients. Yang et al. [71] reported RBEs of 2.35 and 2.42 for
fast neutrons in immature rat hippocampal cells, as determined by two different cell
viability assays. Dagrosa et al. [72] used the cytokinesis-block micronucleus assay and
a cell survival assay in a human colon carcinoma cell line and observed an RBE of 4.4
for neutrons in boron neutron capture therapy. RBEs for neutrons as low as 4 to as high
as 63 have been reported after measuring life-shortening responses in mice [73],
apoptosis [1] and induction of dicentrics [74] in human lymphocytes. These numbers
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clearly indicate that the RBEs for neutrons vary with the biological system, neutron
energy and the end-point. Our RBE values are within the range of what others have
reported.
In conclusion, we found no evidence for a bystander effect following exposure to
fast neutrons (17 MeV average energy) or to doses of cobalt-60 photons equivalent to
5% of the neutron dose. As expected, a bystander effect was seen with high doses of
photons, as evaluated by micronuclei frequencies and nucleoplasmic bridges. These
results will facilitate refined estimates of the risk-benefit ratio of neutron therapy and
may be valuable to those who are concerned about the health effects of exposure of
space travel. We have also shown that these fast neutrons have a relative biological
effectiveness of 2.0 ± 0.13 for micronuclei and 5.8 ± 2.9 for bridges compared to cobalt60. Understanding the biological effects of neutrons may also enable more refined
evaluations of the standards for radiation protection and safety.
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CHAPTER 4
Cytogenetic low-dose hyper-radiosensitivity is observed in human peripheral
blood lymphocytes
INTRODUCTION
The shape of radiation dose-response curves at low doses has been debated.
One reason for the uncertainty of health risks associated with low-dose exposure is the
lack of epidemiological evidence (1). Risk estimates for low doses are predicted from
linear extrapolation of the relationship between dose and risks observed at higher
doses. Linear-no-threshold (LNT) dose-response models are widely used to assess the
risks associated with low-dose exposure (2). According to LNT models, the risks of
genetic damage increase linearly with dose without any threshold. Regulatory agencies
use LNT models to extrapolate risks to low doses from high doses. However in some
systems, there is evidence of non-linearity in the low-dose region that contradicts LNT
models.
Low-dose hyper-radiosensitivity (HRS) is the phenomenon wherein, at doses
below 0.5 Gy, cells are at higher risk of damage per unit dose than at higher doses (3).
Non-linear behavior at low doses has been observed in response to different radiation
types, certain drugs (e.g., cisplatin and bleomycin) and glutathione S-transferase
inhibitors (reviewed in (4)). HRS has been observed in vivo and in many mammalian cell
lines (3, 5). Most in vitro studies measured HRS using clonogenic cell-survival assays
(6, 7). Failure to observe hypersensitivity in some cell lines may be due to variation in
the cell cycle position of the irradiated cells, or to the failure of the underlying molecular
pathways (8).
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The phenomenon of HRS has been predominantly observed when cells are
irradiated in G2 but not in G1 or S (8). Enrichment of MR4 and V79 cells in G1
abolished the elevated levels of cell killing otherwise observed at low doses. This
observation demonstrates that enhanced sensitivity of cells irradiated in G2 results from
failure of ATM-dependent DNA repair which normally arrests progression of damaged
cells into mitosis (9). Low-dose hyper-radiosensitivity has been associated with
abrogation of the G2/M checkpoint in rat fibroblasts (10). There is also evidence that
hydroxyl radicals are involved in HRS (11). Marples et al. (12) found that HRS was
eliminated in V79 cells that were primed with hydrogen peroxide. HRS was first
deduced in mouse models of skin and renal damage in vivo (13, 14) and then observed
in V79 cells acutely irradiated with single doses of X-rays (3). HRS has since been seen
in many mammalian cell lines in response to photons (7, 15) and for different radiation
types (X-rays and negative pi-mesons) and biological endpoints (16-19). Until now no
study has validated the existence of HRS in human peripheral blood lymphocytes in G2
using structural chromosomal aberrations as the endpoint.
Here we provide the first cytogenetic evidence of low-dose hyper-radiosensitivity
in cobalt-60-irradiated human peripheral blood lymphocytes from two healthy adults.
This is the first time that the shape of the dose response in G2 has been characterized
using structural chromosomal aberrations at such low doses of radiation. HRS may
have implications in risk analysis because deviation from LNT models may necessitate
re-evaluation of radiation protection standards. The biological effects of low-dose
radiation and risks associated with these effects should also be considered while
conducting diagnostic and therapeutic treatments involving radiation.
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MATERIALS AND METHODS
Subject recruitment, blood collection, and cell culture
Approval from the Wayne State University Human Investigation Committee (HIC)
was obtained prior to the recruitment of two healthy female adult blood donors aged 25
and 26. Neither donor had ever undergone chemo- or radiation-therapy. Peripheral
blood (50 mL) from each donor was drawn into Vacutainer Sodium Heparin tubes
(Becton Dickinson). Immediately following phlebotomy, blood from each donor was
aliquoted into tissue culture flasks (26 flasks each for G0 and G2 exposures). Blood
(800 μL) was placed into non-vented T25 flasks (Corning, NY and ISC BioExpress,
Kaysville, UT) containing 10 mL of medium consisting of RPMI1640 (GIBCO, Grand
Island, NY or Hyclone, Logan, UT) supplemented with 15% fetal bovine serum (Atlanta
Biologicals, Lawrenceville, GA), 2% phytohemagglutinin (Gibco), 1% penicillin–
streptomycin (100 units/ml penicillin G Sodium, 100 µg/ml streptomycin sulfate in 0.85%
saline; GIBCO, Grand Island, NY) and 2 mM L-glutamine (GIBCO, Grand Island, NY).
The media was pre-warmed to 37C prior to the addition of the blood. Culture flasks
caps were kept loose, and tightened only when being transported and irradiated.
Irradiation, slide preparation and staining
All irradiations were performed at the Gershenson Radiation Oncology Center,
Wayne State University with a Cobalt-60 source in a Theratron 780 radiotherapy unit
(MDS Nordion, Canada), at a dose rate of 0.25 Gy/min. The samples were transported
to and from the cytogenetics laboratory (a 5 minute drive) in an insulated container with
warm packs at 37C. Cells were acutely irradiated at doses of 0, 0.1, 0.2, 0.3, 0.4, 0.5,
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0.6, 0.7, 0.8, 0.9, 1.0, 1.25 and 1.5 Gy. The 0 Gy (control) was sham-irradiated. Careful
consideration was given to the temperature of the cells before, during and after
radiation. During radiation the flasks were in a room where the ambient temperature
was approximately 25C, without warm packs. The flasks that were in this temperature
for the longest duration were those irradiated with 1.5 Gy, which required an exposure
time of 6 minutes. For both G0 and G2 exposures, blood was immediately placed into
culture after the blood draw. For G0 exposures the cells were irradiated immediately
and Colcemid (KaryoMAX, Gibco) was added 44 hours later at a final concentration of
0.1 g/mL. For G2 exposures, blood was irradiated after 46 hours in culture and
Colcemid was added immediately afterwards. After radiation all flasks were placed
upright in a fully humidified incubator with 5% CO2 at 37C. For G0 and G2 exposures
cells were harvested four and two hours after the addition of Colcemid, respectively, i.e.
48 hours after culture initiation. Slides of cells in metaphase were prepared and blockstained with Giemsa using standard techniques.
Scoring of structural chromosomal aberrations
All slides were coded prior to scoring to prevent observer bias. All scoring was
performed on a Nikon Eclipse E200 microscope at 1000X total magnification. One welltrained slide reader scored at least 200 cells in metaphase for each treatment condition.
Cells were scored for structural chromosomal aberrations including chromatid and
chromosome breaks, and chromatid and chromosome exchanges. Gaps were also
recorded but were not included in the final data analyses. The term “total aberrations”
refers to the sum of all the different kinds of chromosomal damage including chromatid
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and chromosome damage for each cell cycle phase, and “total abnormal cells” refers to
the number of cells that had any kind of chromosomal damage.
Statistical Analyses
Linear and non-linear regressions were performed using JMP software (version
6.0, SAS Institute, Inc.) for each aberration type in G2 and G0. Student’s t-test was
used to compare the slopes of the regression lines. P-values <0.05 were considered
statistically significant.
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RESULTS
These data provide the first cytogenetic evidence of low-dose radiation
hypersensitivity in human cells. For both donors and cell cycle phases, we recorded
chromatid and chromosome breaks, and chromatid and chromosome exchanges. The
number of cells scored and the frequency of each aberration type for each treatment
condition are provided in Tables 4.1 and 4.2 for Donors 1 and 2, respectively. As
expected (20), chromatid-type damage was most prevalent in G2 and chromosome-type
damage was most prevalent in G0 (Tables 4.1 and 4.2); for this reason Tables 4.3 and
4.4 report only the most prevalent aberration types associated with each cell cycle
phase. For both donors and cell cycle phases, the frequencies of all aberrations
considered together and the associated regression fits are shown in Figure 4.1 and 4.2.
Summaries of the regression analyses and ratios of the slopes of the low-dose to
high-dose regions for both donors for G2 and G0 are shown in Tables 4.3 and 4.4,
respectively. Doses ≤0.4 Gy were considered as the low-dose region, while doses ≥0.5
Gy were considered as the high-dose region; the 0 Gy (control) group was included in
all regression analyses. The highest doses included in the analyses were 1.25 Gy and 1
Gy for Donors 1 and 2, respectively; doses above these values were excluded to avoid
poor regression fits due to the decline in the frequencies of aberrations at these high
doses for cells irradiated in G2 (Figure 4.1 A and 4.2 A), which are likely due to greater
cell cycle delay of the most heavily damaged cells.
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Table 4.1. Donor 1 data by dose and aberration type for G2 and G0 phases.
Dose
(in Gy)

Number
of cells
scored

All
aberrations
/ 100 cells

Total
number of
abnormal
cells/ 100
cells

Chromatid
breaks/
100 cells

Chromatid
exchanges
/ 100 cells

Chromosome
breaks/
100 cells

Chromosome
exchanges
/100 cells

Donor 1, G2
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1.25
1.5

200
200
200
201
202
201
200
207
200
200
200
204
200

1.5
7.0
34.0
33.8
49.0
34.3
42.0
60.4
63.0
114.0
93.0
149.0
107.0

1.5
6.0
28.0
26.4
29.7
22.9
26.0
30.9
36.5
53.5
43.5
55.4
39.5

0
1.0
25.5
13.9
23.3
22.9
22.5
47.3
32.5
92.5
68.5
108.8
72.5

0
1.0
2.0
8.0
8.4
7.0
7.0
6.8
10.5
16.0
14.5
24.5
19.0

1.0
2.0
2.5
4.5
11.4
2.5
2.5
2.4
2.5
2.5
2.0
5.4
5.0

0.5
3.0
4.0
7.5
5.9
2.0
10.0
3.9
17.5
3.0
8.0
10.3
10.5

201
200
201
200
200
200
200
203
200
200
200
200
200

0
0.5
0.5
3.5
2.5
7.5
9.5
13.8
9.0
11.5
13.0
18.0
24.0

0
0.5
0.5
2.0
2.0
5.0
7.5
9.9
5.5
9.0
8.0
12.5
16.0

0
0
0
1.0
0
0
0
1.5
0.5
0
0.5
0
0

0
0
0
0
0
0
0.5
0
0
0
0
0
0

0
0.5
0.5
1.0
1.5
4.0
5.0
7.9
4.5
6.0
9.0
10.5
14.0

0
0
0
1.5
1.0
3.5
4.0
4.4
4.0
5.5
3.5
7.5
10.0

Donor 1, G0
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1.25
1.5
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Table 4.2. Donor 2 data by dose and aberration type for G2 and G0 phases.
Dose
(in Gy)

Number
of cells
scored

All
aberrations
/ 100 cells

Total
number
of
abnormal
cells/ 100
cells

Chromatid
breaks/
100 cells

Chromatid
exchanges
/ 100 cells

Chromosome
breaks/
100
cells

Chromosome
exchanges
/ 100 cells

Donor 2, G2
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1.25
1.5

200
205
200
201
200
201
200
200
200
200
200
201
200

0
12.2
16.5
24.9
31.0
23.9
32.5
37.5
64.5
74.0
72.0
48.3
40.5

0
9.8
12.5
12.9
23.5
16.4
21.5
23.0
30.5
34.5
35.5
23.4
24.0

0
11.2
15.5
20.9
24.0
17.9
28.0
28.5
56.5
63.0
61.5
39.3
31.0

0
0.5
1.0
3.0
7.0
5.5
4.0
9.0
7.5
9.5
10.0
8.5
9.5

0
0
0
0
0
0.5
0
0
0
0
0.5
0
0

0
0.5
0
1.0
0
0
0.5
0
0.5
1.5
0
0.5
0

2.5
1.0
3.0
2.5
1.0
4.0
3.0
3.5
6.5
10.8
6.5
11.9
20.5

2.0
1.0
2.5
2.5
1.0
3.5
2.0
3.0
4.5
8.4
6.5
9.5
16.0

0
0
0
0
0
0
0
0
0
0
0
0
0.5

0
0
0
0
0
0
0
0
0
0
0
0
0

2.0
1.0
2.0
1.5
0.5
1.5
1.5
2.0
3.0
6.9
2.5
8.0
14.5

0.5
0
1.0
1.0
0.5
2.5
1.5
1.5
3.5
3.9
4.0
4.0
5.5

Donor 2, G0
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1.25
1.5

200
200
200
200
200
201
200
200
200
203
200
201
200
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Table 4.3. G2 regression analyses and ratios of slopes.
Aberration type/100
metaphases

Slope (linear coefficient ± S.E)

Low-dose*
Linear fit

Ratio of
slopes

p- value

High-dose†
Linear-quadratic fit

Donor 1
All
aberrations

121.85 ± 20.56

38.25 ± 40.63

3.2

0.006

Abnormal
cells
Chromatid
breaks
Chromatid
exchanges

76.77 ± 21.08

48.36 ± 16.70

1.6

0.08

59.47 ± 27.17

21.14 ± 49.97

2.8

0.14

23.80 ± 4.99

3.70 ± 5.52

6.4

0.003

Average

3.5 ± 1.02

Donor 2
All
aberrations

74.70 ± 6.48

25.05 ± 31.45

3.0

0.003

Abnormal
cells
Chromatid
breaks
Chromatid
exchanges

50.18 ± 10.04

32.02 ± 6.86

1.6

0.026

57.68 ± 8.23

14.97 ± 32.14

3.9

0.009

16.50 ± 4.32

9.64 ± 5.69

1.7

0.084

Average
*
†

2.5 ± 0.55

0 to 0.4 Gy
0, and 0.5 Gy-1.25 Gy for Donor 1; 0, and 0.5-1.0 Gy for Donor 2.
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Table 4.4. G0 regression analyses and ratios of slopes.
Aberration
type/100
metaphases

Slope (linear coefficient ± S.E)

Low-dose

Donor 1
All
aberrations

*

Type High-dose‡
of fit
(L, LQ)†

Ratio of
slopes

pvalue

Type
of fit
(L, LQ)†

8.00 ± 3.05

L

13.28 ± 2.01

L

0.60

0.18

Abnormal
cells

5.50 ± 1.26

L

11.16 ± 5.78

LQ

0.49

0.03

Chromosome
breaks

3.50 ± 0.50

L

7.56 ± 4.48

LQ

0.46

0.02

Chromosome
exchanges

3.50 ± 1.60

L

5.75 ± 3.23

LQ

0.61

0.27

Average
Donor 2
All
aberrations

0.54 ± 0.03

-1.50 ± 3.30

L

6.13 ± 2.86

L

-0.24

0.06

Abnormal
cells

-0.50 ± 2.75

L

5.30 ± 2.20

L

-0.09

0.07

Chromosome
breaks

-2.50 ± 1.89

L

2.57 ± 2.29

L

-0.97

0.06

Chromosome
exchanges

1.00 ± 1.41

L

0.64 ± 3.05

LQ

1.56

0.42

Average
*

0.06 ± 0.53

0 to 0.4 Gy
L= Linear, LQ= Linear-quadratic
‡
0, and 0.5 Gy-1.25 Gy for Donor 1; 0, and 0.5-1.0 Gy for Donor 2.
†

99
For G2, the low-dose region slopes were calculated using a linear regression
model, while the slopes of the high-dose regions were calculated using a linearquadratic model, in accordance with conventional radiation dosimetry models (21). For
Donor 1, for all aberrations and chromatid exchanges, the low-dose region slopes were
significantly steeper (p<0.05) than the linear term of the linear-quadratic model of the
high-dose region (Table 4.3). For Donor 2 every aberration type exhibited a steeper
slope at the low doses (p<0.05) (Table 4.3). The average of the ratios of the low-dose
region slopes to the high-dose region slopes was 3.50±1.02 (mean±S.E.) and
2.50±0.55, for Donors 1 and 2, respectively (Table 4.3); these ratios were not
significantly different (t-test, p>0.05).
No low-dose radiation hypersensitivity was observed in G0 for either donor
(Table 4.4). For Donor 1 cells irradiated in G0, all the low-dose region slopes were
calculated using a linear regression model and all the high-dose region slopes except
for all aberrations considered together were calculated using a linear-quadratic model.
The decision whether to use a linear or a linear-quadratic model was based on
whichever model gave the best fit and made the most biological sense (21). For Donor
2 cells irradiated in G0, all the low-dose and high-dose region slopes were calculated
using a linear model except that the high-dose region slope for chromosome exchanges
was calculated using a linear-quadratic model. Linear fits were chosen over linearquadratic fits for high-doses in G0 for Donor 2 because linear-quadratic fits either gave
negative linear or negative dose-squared coefficients. Low-dose hyper-radiosensitivity
was not observed in G0 for either donor, i.e. the slope of the low-dose region was not
higher than the slope obtained by back-extrapolating from the high-dose region. The
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average of the ratios of low-dose region slopes to the high-dose region slopes was
0.54±0.03 for Donor 1 and 0.06±0.53 (mean±S.E.) for Donor 2 (Table 4.4); these ratios
were not significantly different (t-test, p>0.05).
The most reasonable way to compare the amounts of chromosome damage in
both cell cycle phases is to evaluate the frequencies of all aberration types considered
together, because as noted above, the types of damage differ in G0 and G2. Figure 4.1
B and 4.2 B show the regression fits for all aberrations considered together for donors 1
and 2, respectively, for G2 and G0 exposures. For cells irradiated in G2, the slope of the
low-dose region is approximately 3 times steeper (p<0.01) than that obtained by backextrapolation from high doses (Figure 4.1 A, 4.2 A, Table 4.3), indicating low-dose
hyper-radiosensitivity. For cells irradiated in G0, the slope of low-dose region is not
steeper than the high-dose region slope for either donor (Figure 4.1 B and 4.2 B),
indicating an absence of low-dose hyper-radiosensitivity.
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Figure 4.1 Upper panel: Donor 1 cells irradiated in G2, where the slopes of the lowand high-dose regions were fitted to linear and linear-quadratic models, respectively.
Cells show hyper-radiosensitivity up to 0.4 Gy. The low-dose region slope is higher
than that obtained by back-extrapolation of the high-dose region slope, indicating lowdose hyper-radiosensitivity. Lower panel: Donor 1 G0 slopes of the low- and high-dose
regions fitted to linear models, for all aberration types considered all together. No low
dose hyper-radiosensitivity was observed in G0. The dashed line in panel B is for both
low-and high-dose data together fitted with a linear-quadratic model.
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Figure 4.2 Upper panel: Donor 2 cells irradiated in G2, where the slopes of the lowand high-dose regions were fitted to linear and linear-quadratic models, respectively.
Cells show hyper-radiosensitivity up to 0.4 Gy. The low-dose region slope is higher
than that obtained by back-extrapolation of the high-dose region slope, indicating lowdose hyper-radiosensitivity. Lower panel: Donor 2 G0 slopes of the low- and high-dose
regions fitted to linear models, for all aberration types considered all together. No low
dose hyper-radiosensitivity was observed in G0. The dashed line in panel B is for both
low-and high-dose data together fitted with a linear-quadratic model.
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Radiation sensitivity, i.e. the cytogenetic effect per unit dose, is illustrated in
Figure 4.3 for each donor and cell cycle phase. Here, the same data as shown in Figure
4.1 and 4.2 are re-plotted such that the vertical axis is the frequency of aberrations per
unit dose, i.e. the slope of the line from the 0-dose value to each individual data point.
For both donors, there is evidence of hypersensitivity in G2 at doses ≤0.4 Gy compared
to doses ≥0.5 Gy. No low-dose hyper-radiosensitivity was observed in G0. Compared to
Donor 1, Donor 2 showed a more consistent pattern of hyper-radiosensitivity. For Donor
2, the effect per unit dose for all doses ≤0.4 Gy was high with cells being most
radiosensitive at 0.1 Gy. However, for Donor 1, the 0.1 Gy dose had low radiosensitivity, and doses 0.2-0.4 Gy showed sensitivity higher than 0.1 Gy.

Figure 4.3 Radiation sensitivity of cells irradiated in G2 compared to cells irradiated in
G0 for all aberration types considered together. Cells irradiated in G2 clearly show more
hypersensitivity than cells irradiated in G0. For Donor 2, G0 phase, the values for 0.1
and 0.4 Gy were negative and are not shown (indicated by arrows).
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DISCUSSION
The goal of the work described here was to characterize the shape of the
cytogenetic dose-response curve for low doses of cobalt-60 gamma rays without any
prejudice towards the direction of any non-linearity that might be observed. Our data
provide the first cytogenetic evidence of low-dose radiation hypersensitivity in human
peripheral blood lymphocytes in response to cobalt-60 gamma rays. The spectrum of
chromosomal aberrations observed in G2 and G0 is in accordance with the classical
theory of aberration formation where chromosome-type aberrations are induced in cells
irradiated in G0 and chromatid-type aberrations are observed G2 (20). We did observe
low levels of chromosome-type damage in G2-irradiated cells which are likely due to the
presence of a few cells that were in S-phase at the time of exposure. We also observed
small amounts of chromatid-type damage in G0-irradiated cells, which appear to be
spontaneous and not radiation-induced. These latter aberrations may be due to
endogenous reactive oxygen species (ROS) which have been reported to play a role in
inducing chromatid-type aberrations in G0-irradiated cells (22).
For G2-irradiated cells, both donors show hyper-radiosensitivity at low doses.
There is variability in the radiation responses between the two donors which may be
attributable to genetic differences. For both donors, the low-dose region slope is three
times steeper (p<0.01) than the slope obtained by back-extrapolation from high doses,
clearly providing evidence of cytogenetic low-dose hyper-radiosensitivity. Our results
are in agreement with the low-dose hyper-radiosensitivity that has been previously
shown to occur for cell killing in vitro and in vivo in different cell systems including
normal and tumor cells (3, 23, 24), and subsequently reviewed in (6). In the present
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study the hyper-radiosensitivity peak was observed at 0.1 and 0.2 Gy for Donors 2 and
1, respectively. The aberration frequencies when considered together were fairly
constant over the dose range 0.2-0.5 Gy which may be due to induction of DNA repair
mechanisms (7). The full spectrum of chromosomal aberrations was analyzed here,
which may provide insight to the underlying mechanisms of low-dose hyperradiosensitivity. The presence of chromatid breaks with the highest damage per unit
dose at doses up to 0.4 Gy suggests that at least some cells damaged by these low
doses were able to enter mitosis without these breaks being repaired. The peak dose
for hyper-radiosensitivity differs and may depend on the cell type, endpoint being
evaluated and radiation type. The underlying mechanism of low-dose hyperradiosensitivity as hypothesized originally by Marples et al. (8) is the failure to activate
the ATM protein and thus bypass the G2/M checkpoint due to sub-threshold DNA
damage induced at these low doses. In another study, radiosensitivity and formation of
ROS have been shown to be closely associated following irradiation (25).
For cells irradiated in G0, the slope of the low dose region is not steeper than the
high-dose region slope for either donor, indicating an absence of low-dose hyperradiosensitivity. This suggests that cells have enough time for repair if they are
irradiated in G0, because cells are known to be more radioresistant in G0/S compared
to G2 (26). Our results are in contrast those of Nasnova et al. (27) who observed
hypersensitivity in irradiated G0 lymphocytes at 1-7 cGy. Their conclusions are based
on the observation of significant amounts of chromatid-type aberrations in G0. However,
they did not provide any conclusive reason for their observations, which are in contrast
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to the classical norm (20), and may simply be due to ROS-related baseline DNA
damage (22).
Low-dose hyper-radiosensitivity could be exploited clinically if radiotherapy were
delivered in a large number of dose fractions, each of which is <0.5 Gy. There is a
possibility of taking advantage of the sensitivity of tumor cells at low doses which are
otherwise resistant to radiation at higher doses (26). Two studies have reported hyperradiosensitivity in a tumor model system following fractionated X-irradiation (18, 28). In
a cell survival study, human radioresistant T98G glioblastoma cells were found to show
marked radiosensitivity to low doses (24). In a related study which also evaluated
clonogenic survival, five human radioresistant glioma cell lines demonstrated
radiosensitivity (29). Recently, very promising results were obtained in a clinical trial
where glioblastoma patients showed a significant increase in overall survival using ultra
fractionation protocols (three times daily dose of 0.8 Gy instead of a single large dose of
2 or 2.4 Gy (30). To further identify the clinical potential of using the phenomenon of
low-dose hyper-radiosensitivity in radiotherapy, a similar cytogenetic study could be
performed on tumor cells to determine whether they exhibit low-dose hyperradiosensitivity. Information obtained should be relevant to radiation oncologists when
administering radiotherapy to cancer patients.
The findings reported here are in accordance with previous in vitro and in vivo
cell killing studies (3, 5, 6, 16). As reviewed in (31), the report of the French Academy of
Sciences and the French Academy of Medicine also questions the validity of the LNT
model. However, our data are in contrast with conclusions made by BEIR VII that
supports LNT as an accurate risk model (31).
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The extent to which low doses might be harmful to human cells will depend on
the type of cells, their sensitivity to radiation, and on the fraction of cells in the most
sensitive cell cycle phase. Quantifying the effect that low-dose hyper-radiosensitivity
has on the human body may be difficult because of differential sensitivity among cell
types, which may be at least partially attributable to differences in the length of their cell
cycle phases. The net effect of low-dose hyper-radiosensitivity on cancer risks in cell
populations and tissues will depend on whether the increased damage occurring at
these low doses, as reported here, increases cytotoxicity and/or the number of
survivable mutations. Further work needs to be done to couple mutational assays with
the ultimate fate of cells after damage by low doses of radiation.
The work reported here is the first to provide cytogenetic evidence of low-dose
hyper-radiosensitivity in human cells using structural chromosomal aberrations. There is
a potential of exploiting the phenomenon of low-dose hyper-radiosensitivity in
radiotherapy to kill tumor cells that may be otherwise resistant to higher doses. These
results indicate that LNT models may not always correctly assess radiation risk the lowdose region.
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Chapter 2:
Micronuclei have been used extensively in studies as an easily-evaluated
indicator of DNA damage but little is known about their association with other types of
damage such as nucleoplasmic bridges and nuclear buds. Radiation-induced
clastogenic events were evaluated via the cytokinesis-block micronucleus assay in two
normal human lymphoblastoid cell lines exposed to neutrons or gamma radiation.
Micronuclei, nucleoplasmic bridges and nuclear buds were enumerated by recording the
coincident presence of these endpoints within individual cells, and the associations
among these three endpoints were evaluated for all treatment conditions. The common
odds ratios for micronuclei and nucleoplasmic bridges were found to be significantly
larger than unity, indicating that the presence of one or more micronuclei in a cell
imposes a significant risk for having one or more nucleoplasmic bridges in that same
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cell, and vice versa. The strength of this association did not change significantly with
radiation dose. Common odds ratios for association between micronuclei and buds, and
between bridges and buds were also found to be significantly higher than unity.
However, associations between micronuclei and buds could not be calculated for some
treatments due to heterogeneity in the odds ratios, and hence may depend on radiation
dose. This study provides evidence for how paired analyses among genetic endpoints in
the cytokinesis-block micronucleus assay can provide information concerning
abnormalities

of

cell

division

and

possibly

about

structural

chromosomal

rearrangements induced by radiation.
Chapter 3:
Bystander effects have been observed repeatedly in mammalian cells following
photon and alpha particle irradiation. However, few studies have been performed to
investigate bystander effects arising from neutron irradiation. Here we asked whether
neutrons also induce a bystander effect in two normal human lymphoblastoid cell lines.
These cells were exposed to fast neutrons produced by targeting a near-monoenergetic
50.5 MeV proton beam at a Be target (17 MeV average neutron energy), and irradiatedcell conditioned media (ICCM) was transferred to unirradiated cells. The cytokinesisblock micronucleus assay was used to quantify genetic damage in radiation-naïve cells
exposed to ICCM from cultures that received 0 (control), 0.5, 1, 1.5, 2, 3 or 4 Gy
neutrons. Cells grown in ICCM from irradiated cells showed no significant increase in
the frequencies of micronuclei or nucleoplasmic bridges compared to cells grown in
ICCM from sham irradiated cells for either cell line. However, the neutron beam has a
photon dose-contamination of 5%, which may modulate a neutron-induced bystander
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effect. To determine whether these low doses of contaminating photons can induce a
bystander effect, cells were irradiated with cobalt-60 at doses equivalent to the percent
contamination for each neutron dose. No significant increase in the frequencies of
micronuclei or bridges was observed at these doses of photons for either cell line when
cultured in ICCM. As expected, high doses of photons induced a clear bystander effect
in both cell lines for micronuclei and bridges (p < 0.0001). These data indicate that
neutrons do not induce a bystander effect in these cells. Finally, neutrons had a relative
biological effectiveness of 2.0 ± 0.13 for micronuclei and 5.8 ± 2.9 for bridges compared
to cobalt-60. These results may be relevant to radiation therapy with fast neutrons and
for regulatory agencies setting standards for neutron radiation protection and safety.
Chapter 4:
The shape of the ionizing radiation response curve at very low doses has been
the subject of considerable debate. Linear-no-threshold (LNT) models are widely used
to estimate risks associated with low dose exposures. However, the low-dose hyperradiosensitivity (HRS) phenomenon, in which cells are especially sensitive at low doses
but then show increased radioresistance at higher doses, provides evidence of
nonlinearity in the low dose region. HRS is more prominent in the G2 phase of the cell
cycle than the G0/G1 or S phases. Here I provide the first cytogenetic evidence of lowdose hyper-radiosensitivity in human peripheral blood lymphocytes using structural
chromosomal aberrations. Human peripheral blood lymphocytes from two normal
healthy female donors were acutely exposed to cobalt-60 gamma rays in either G0 or
G2 using closely-spaced doses ranging from 0-1.5 Gy. Structural chromosomal
aberrations were enumerated and the slopes of the regression lines at low doses (0-0.4
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Gy) were compared with doses of 0.5 Gy and above. HRS was clearly evident in both
donors for cells irradiated in G2. No HRS was observed in cells irradiated in G0. The
radiation effect per unit dose was 2.5-3.5 fold higher for doses ≤0.4 Gy than >0.5 Gy.
These data provide the first cytogenetic evidence for the existence of HRS in human
cells irradiated in G2 and suggest that LNT models may not always be optimal for
making radiation risk assessments at low doses.
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